Research visual
Humana Research

The physician-insurer dynamic must shift to successfully implement value-based payments

Beveridge RA, Happe LE, Funk M. The physician-insurer dynamic must shift to successfully implement value-based payments. Healthcare. September 3, 2016. Epub ahead of print.

The physician-insurer dynamic must shift to successfully implement value-based payments

Presentation at diagnosis and intensity of interventions in people with lung cancer

Powell AC, Mirhadi AJ, Loy BA, Long JW, Kren EM, Gupta AK. Presentation at diagnosis and intensity of interventions in people with lung cancer. J Clin Oncol. 2016;34(suppl; abstr e20052).

Presentation at diagnosis and intensity of interventions in people with lung cancer. | 2016 ASCO Annual Meeting | Abstra…

Refill patterns with oral oncolytic medications

Dye JT, Murty S, Nsiah I, Kennedy K, Whisman T, Worley K. Refill patterns with oral oncolytic medications. J Clin Oncol. 2016;34(suppl; abstr e18216).

Refill patterns with oral oncolytic medications. | 2016 ASCO Annual Meeting | Abstracts | Meeting Library

Changes in prevalence and healthcare utilization rates among the population with autism spectrum disorder following the Affordable Care Act

Mohanty S, Treviño LA, Smith N, Cope P, Ruble M, Gresky D. Changes in prevalence and healthcare utilization rates among the population with autism spectrum disorder following the Affordable Care Act. Poster presentation at: AcademyHealth 2016 Annual Research Meeting. June 26-28, 2016; Boston, MA.

http://test-apps.humana.com/marketing/documents.asp?file=2897934

Effectiveness of colorectal cancer screening messaging among individuals non-compliant with guidelines

Jhaveri M,  Cambon J, Cordier T, Haugh G.  Effectiveness of colorectal cancer screening messaging among individuals non-compliant with guidelines.  J Natl Compr Canc Netw. 2016;14(5.5):e1-e30.

http://apps.humana.com/marketing/documents.asp?file=2857348

Synchronized prescription refill program to improve medication adherence: a prospective study

Doshi JA, Lim R, Li P, Young PP, Lawnicki VF, State JJ, Troxel A, Volpp K. Synchronized prescription refill program to improve medication adherence: a prospective study. Health Affairs. 2016;35(8):1504-1512.

http://content.healthaffairs.org/content/35/8/1504.abstract

Does hepatitis C treatment adherence affect the risk of liver transplant? A historical cohort study

Ems E, Rasca P, Anderson C, Gregory F, Worley K, Brill J, Holt W. Does hepatitis C treatment adherence affect risk of liver transplantation? A historical cohort study. J Manag Care Pharm. 2016;22(7):863-71.

Does Hepatitis C Treatment Adherence Affect Risk of Liver Transplantation? A Historical Cohort Study. - PubMed - NCBI

CT and MRI 8 year utilization trends in the context of a non-denial prior authorization program

Powell A, Levin D, Kren E, Beveridge R, Long J, Gupta A. CT and MRI 8 year utilization trends in the context of a non-denial prior authorization program. ePoster presentation at: American College of Radiology Annual Meeting. May 15-19, 2016; Washington, DC.

http://apps.humana.com/marketing/documents.asp?file=2859844

The presence of mental health conditions among patients with congestive heart failure and the impact on health outcomes: a propensity score matched study

Bhattacharya R, Ruble M, Renda R, Gresky DP, Treviño LA. The presence of mental health conditions among patients with congestive heart failure and the impact on health outcomes: a propensity score matched study. Poster presentation at: International Society of Pharmacoeconomics and Outcomes Research 21st Annual Meeting. May 21-26, 2016; Washington DC.

http://apps.humana.com/marketing/documents.asp?file=2890173

Human papilloma virus vaccine initiation in an insured population

Espinosa C, Woods C, Marshall G, Happe L, Harkins T, Nair V, Knispel J, Van Amerongen V, Ma Q, Smith M. Human papilloma virus vaccine initiation in an insured population. Poster presentation at: Pediatric Academic Society. April 30-May 3, 2016; Baltimore, MD.

http://apps.humana.com/marketing/documents.asp?file=2882100

What are the demographic, clinical and lifestyle factors associated with Unhealthy Days among a working population?

McRoberts B, Radmacher M, Slabaugh SL, Bahouth W. What are the demographic, clinical and lifestyle factors associated with Unhealthy Days among a working population? Poster presentation at: 26th Annual Art & Science of Health Promotion Conference. April 27-29, 2016; Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=2864199

The H-E-B “Fresh Perspectives” partnership in San Antonio

McGrath E, Staehly M. The H-E-B “Fresh Perspectives” partnership in San Antonio. Poster presentation at: 26th Annual Art and Science of Health Promotion Conference. April 25-29, 2016; Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=2860637

Comparative effectiveness analysis of rapid-acting insulin therapies in a large national health plan

Rasca P, Meah Y, Ellis JJ, Saverno K. Comparative effectiveness analysis of rapid-acting insulin therapies in a large national health plan. Poster presentation at: Academy of Managed Care & Specialty Pharmacy Annual Meeting. April 19-22, 2016; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2859935

Comparison of utilization and outcomes in patients with hemophilia receiving plasma-derived factors versus recombinant factors

Nsiah I, Aten A, Ellis J, Gregory F, Saverno, K. Comparison of utilization and outcomes in patients with hemophilia receiving plasma-derived factors versus recombinant factors. Poster presentation at: Academy of Managed Care & Specialty Pharmacy Annual Meeting. April 19-22, 2016; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2859584

Ensuring quality healthcare using an innovative hybrid approach to licensure and credentialing standards

Roberts M, Kartha L, Felker A, Weinstein C, Kulkarni T. Ensuring quality healthcare using an innovative hybrid approach to licensure and credentialing standards. Poster presented at: American College of Medical Quality. March 30-Apr 2, 2016; Washington, DC.

http://apps.humana.com/marketing/documents.asp?file=2857257

Antipsychotic prescribing patterns in a Medicare Advantage population of older individuals with dementia

Kester R, Unützer J, Hogan D, Huang H. Antipsychotic prescribing patterns in a Medicare Advantage population of older individuals with dementia. Poster presentation at: American Association for Geriatric Psychiatry Annual Meeting. March 17-20, 2016; Washington DC.

http://apps.humana.com/marketing/documents.asp?file=2882113

Impact of out-of-pocket costs on initial and subsequent prescription refills among new initiators of biologic therapies indicated for RA

Hopson S, Saverno K, Liu LZ, AL-Sabbagh A, Orazem J, Pasquale MK. Impact of out-of-pocket costs on initial and subsequent prescription refills among new initiators of biologic therapies indicated for RA. JMCP 2016; 22(2):122-130.

Leveraging predictive modeling to improve the participant identification process for transition to dialysis support programs

Cockrell M, Dong Y, Hines H, Haugh G, Gopal V, Beveridge R, Prewitt T. Leveraging predictive modeling to improve the participant identification process for transition to dialysis support programs. Journal of the American Society of Nephrology. 2015(26):926A.

Healthcare resource utilization change post cardiac resynchronization therapy (CRT) implant based on data from a large US health insurance carrier

Dong Y, Chiguluri V,  Haugh G, Renda A, Prewitt T, Gopal V. Healthcare resource utilization change post cardiac resynchronization therapy (CRT) implant based on data from a large US health insurance carrier. Poster Presentation at: Heart Rhythm Society Annual Scientific Sessions. May, 2015; Boston, MA.

https://apps.humana.com/marketing/documents.asp?file=2631044

Use of add-on treatment to metformin monotherapy for patients with type 2 diabetes and suboptimal glycemic control: a U.S. database study

Yu S, Schwab P, Bian B, Radican L, Tuncelli K. Use of add-on treatment to metformin monotherapy for patients with type 2 diabetes and suboptimal glycemic control: a U.S. database study. J Manag Care Spec Pharm. 2016;22(3):272-80.

http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.22.3.272

Patterns of care in patients with metastatic renal cell carcinoma among a US payer population

Miller LA, Stemkowski S, Saverno K, Lane D, Tao Z, Hackshaw M, Loy B. Patterns of care in patients with metastatic renal cell carcinoma among a US payer population. J Manag Care Spec Pharm, 2016;22(3):219-226

http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.22.3.219

Evaluation of molecular testing patterns in metastatic non-small cell lung cancer at a large US health plan

MacLean EA, Louder AM, Saverno KR, Smith G, Mardekian J, Bruins C, Ward M, Sweetman RW, Pasquale M. Evaluation of molecular testing patterns in metastatic non-small cell lung cancer at a large US health plan. American Journal of Managed Care 2016; 22(2): e60-e67.

Evaluation of molecular testing patterns in metastatic non-small cell lung cancer at a large U.S. health plan. | 2014 AS…

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs

Schwab P, Saundankar V, Bouchard J, Wintfeld N, Suehs B, Moretz C, Allen E, DeLuzio A. Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs. BMJ Open Diabetes Research and Care 2016;4:e000099. doi:10.1136/bmjdrc-2015-000099

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications,…

COPD exacerbations associated with the modified medical research council scale and COPD assessment test among Humana’s medicare members

Pasquale MK, Xu Y, Baker CL, Zou KH, Teeter JG, Renda AM, Davis CC, Lee TC, Bobula J. COPD exacerbations associated with the modified medical research council scale and COPD assessment test among Humana’s medicare members. International Journal of COPD 2016; 11:111-121.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716734/pdf/copd-11-111.pdf

Effect of new drug therapies on current metastatic melanoma treatment patterns

Kennedy K, Murty S, Dye J, Whisman T, Worley K. Effect of new drug therapies on current metastatic melanoma treatment patterns. J Natl Compr Canc Netw. 2016;14(5.5):e1-e30.

http://test-apps.humana.com/marketing/documents.asp?file=2852434

Getting to goals: understanding the nature and achievement of health-related goals in coaching

Wallace A, Bogard M, Kukreja V, Prybol K, Zbikowski SM. Getting to goals: understanding the nature and achievement of health-related goals in coaching. Poster presentation at: 37th Annual Meeting & Scientific Sessions of the Society of Behavioral Medicine. March 30 - April 2, 2016; Washington DC.

http://apps.humana.com/marketing/documents.asp?file=2840487

Trusted third party influencers for medication adherence

Relish M, Young P, Vogel V, et al. Trusted third party influencers for medication adherence. Circ Cardiovasc Qual Outcomes. 2016;9(Suppl 2):A266.

http://apps.humana.com/marketing/documents.asp?file=2834104

Disparities in mortality outcomes in Medicare

Mendes S, Caplan A, Olson V, Beveridge R. Disparities in mortality outcomes in Medicare. Poster presentation at: Preventive Medicine. February 24-27 2016; Washington DC.

http://apps.humana.com/marketing/documents.asp?file=2838615

Do case rates affect physicians’ clinical practice in radiation oncology

Loy BA, Shkedy, CI, Powell AC, Happe LE, Royalty JA, Miao MT, Smith GL, Long JW, Gupta AK.  Do case rates affect physicians’ clinical practice in radiation oncology? PLoS One. 2016;11(2):e0149449.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752271/pdf/pone.0149449.pdf

Variations in the rates of type 1 and type 2 diabetes in a managed care population stratified by age, geographic region, and insurance type

Slabaugh SL, Curtis B, Clore GS, et al. Variations in the rates of type 1 and type 2 diabetes in a managed care population stratified by age, geographic region, and insurance type. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2574572

Validation of febrile seizures identified in the mini-sentinel post-licensure rapid immunization safety monitoring (PRISM) system

Kawai AT, Martin D, McMahill-Walraven CN, et al. Validation of febrile seizures identified in the mini-sentinel post-licensure rapid immunization safety monitoring (PRISM) system. Poster presentation at: Infectious Disease Week. October 8-14, 2014; Philadelphia, PA.

http://apps.humana.com/marketing/documents.asp?file=2574559

Utilization of paliperidone long-acting injection among Medicare Advantage and Medicare Prescription Drug Plan members

Suehs B, Li Y, Howe A, et al. Utilization of paliperidone long-acting injection among Medicare Advantage and Medicare Prescription Drug Plan members. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 17th Annual International Meeting. June 2-6, 2012; Washington, DC.

http://apps.humana.com/marketing/documents.asp?file=2574546

Understanding predictors of opioid abuse: predictive model development and validation

Dufour R, Mardekian J, Pasquale MK, et al. Understanding predictors of opioid abuse: predictive model development and validation. Poster presentation at: Academy of Managed Care Pharmacy Nexus 2013. October 15-18, 2013; San Antonio, TX.

http://apps.humana.com/marketing/documents.asp?file=2574533

Understanding patient preferences associated with the use of biologic therapies for RA: results of a conjoint analysis

Louder A, Saverno K, Singh A. et al. Understanding patient preferences associated with the use of biologic therapies for RA: results of a conjoint analysis. Poster presentation at: American College of Rheumatology Annual Meeting. November 14-19, 2014; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2542995

The Humana database - a data source for pharmacoepidemiologic research

Michels SL, Uribe C. The Humana database - a data source for pharmacoepidemiologic research. Poster presentation at: 28th Annual International Conference for Pharmacoepidemiology and Therapeutic Risk Management. August 23-26, 2012; Barcelona, Spain.

http://apps.humana.com/marketing/documents.asp?file=2574520

Structured advanced care planning facilitated by case managers

Rodkey W, Morrison J, Rackow E. Structured advanced care planning facilitated by case managers. Poster presentation at: Palliative Care in Oncology Symposium. October 24-25, 2014; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2645227

Significant improvement of severe low back pain after breast reduction surgery due to macromastia, a case report

Restrepo A. Significant improvement of severe low back pain after breast reduction surgery due to macromastia, a case report. Poster presentation at: American Academy of Physical Medicine and Rehabilitation Annual Assembly and Technical Exhibition. November 13-16, 2014; San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2645214

Segmentation of a Medicare Advantage population using the Diabetes Complications Severity Index (DCSI)

Chiguluri V, Cusano D, Glasheen W, et al. Segmentation of a Medicare Advantage population using the Diabetes Complications Severity Index (DCSI). Poster presentation at: American Public Health Association 142nd Annual Meeting and Exposition. November 15-19, 2014; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2645201

Retrospective cohort analysis of the patterns and predictors of metformin treatment change in a Medicare Advantage patient population from a large national health plan

Hazel-Fernandez L, Xu Y, Moretz C, et al. Retrospective cohort analysis of the patterns and predictors of metformin treatment change in a Medicare Advantage patient population from a large national health plan. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574507

Relative adherence across sites of care for infliximab patients with Crohn's disease

Michels SL, Eyck T, Vanderpoel J, et al. Relative adherence across sites of care for infliximab patients with Crohn's disease. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574494

Racial/ethnic and gender differences in severity of diabetes-related complications, healthcare resource use, and costs among Medicare Advantage recipients

Hazel-Fernandez L, Li Y, Nero D, et al. Racial/ethnic and gender differences in severity of diabetes-related complications, healthcare resource use, and costs among Medicare Advantage recipients. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574481

Prevalence of opioid abuse and related costs in a commercial managed care population

Pasquale M, Joshi AV, Dufour R, et al. Prevalence of opioid abuse and related costs in a commercial managed care population. Poster presentation at: Academy of Managed Care Pharmacy Educational Conference. October 3-5, 2012; Cincinnati, OH.

http://apps.humana.com/marketing/documents.asp?file=2574468

Predictive meta-modeling to quantify future health risk and identify individuals for clinical programs aimed at improving health outcomes and quality of care

Chui S, Zahedi H, Gopal V. Predictive meta-modeling to quantify future health risk and identify individuals for clinical programs aimed at improving health outcomes and quality of care. Poster presentation at: Society for Medical Decision Making 36th Annual North American Meeting. October 18-22, 2014; Miami, FL.

http://apps.humana.com/marketing/documents.asp?file=2540824

Potential drug-drug interactions and opioid use among painful diabetic peripheral neuropathy Medicare members newly started on pregabalin or duloxetine

Eyck LT, Sadosky A, Ellis J, et al. Potential drug-drug interactions and opioid use among painful diabetics peripheral neuropathy Medicare members newly started on pregablin or duloxetine. Poster presentation at: American Diabetes Association 74th Scientific Sessions. June 13-17, 2014; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2574325

Patterns of lubiprostone utilization in a large managed care population

Sussman D, Tamariz L, Droege M, Harkins T, et al. Patterns of lubiprostone utilization in a large managed care population. Poster presentation at: Digestive Disease Week. May 1-5, 2010; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2574312

Patterns of lubiprostone use and costs in a large health benefits company

Sussman D, Tamariz L, Droege M, Harkins T, et al. Patterns of lubiprostone use and costs in a large health benefits company. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 15th Annual International Meeting. May 15-19, 2010; Atlanta, GA.

http://apps.humana.com/marketing/documents.asp?file=2574286

Out-of-pocket costs and prescription reversals: the case of oral linezolid

Pasquale M, Louder AM, Deminski MC, et al. Out-of-pocket costs and prescription reversals: the case of oral linezolid. Poster presentation at: Academy of Managed Care Pharmacy 25th Annual Meeting and Expo. April 2-5, 2013; San Diego, CA

http://apps.humana.com/marketing/documents.asp?file=2574273

Opportunities and challenges in providing face-to-face and telephonic MTM services to a commercially-insured population

Crawford S, Touchette DR, Sharp LK, et al. Opportunities and challenges in providing face-to-face and telephonic MTM services to a commercially-insured population. Poster presentation at: Academy of Managed Care Pharmacy Nexus. October 7-10, 2014; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2645188

Leveraging strategies on health information technology to maximize health outcomes

Ettel DL, Meinke VA, Ettel GL, Meola PP. Leveraging strategies on health information technology to maximize health outcomes. Poster presentation at: AcademyHealth Annual Research Meeting. June 8-10, 2014; San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2645162

Knee and hip replacements: changes in healthcare utilization and costs from pre- to post-surgery for Medicare Advantage members

Pasquale M, Louder A, Cheung RY, et al.  Knee and hip replacements: changes in healthcare utilization and costs from pre- to post-surgery for Medicare Advantage members.  Poster presentation at: American Pain Society Conference 33rd Annual Scientific Meeting. April 30-May 3, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2574247

Improved survival with telephonic care management

Hall B, Yang M, Painter P, Ettel D, Zubieta M, Rackow E. Improved survival with telephonic care management. Poster presentation at: Society for Medical Decision Making 36th Annual North American Meeting. October 18-22, 2014; Miami, FL.

http://apps.humana.com/marketing/documents.asp?file=2520232

Impact of roflumilast on COPD exacerbations, healthcare utilization and costs in a Medicare Advantage population

Ellis J, Sun SX, Moll K, et al. Impact of roflumilast on COPD exacerbations, healthcare utilization and costs in a Medicare Advantage population. Poster presentation at: American Thoracic Society International Conference. May 16-21, 2014; San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2574234

Impact of patient behaviors and attitudes on teriparatide adherence in a Medicare Part D population

Hazel-Fernandez L, Foater SA, Uribe C, et al. Impact of patient behaviors and attitudes on teriparatide adherence in a Medicare Part D population. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 16th Annual International Meeting. May 21-25, 2011; Baltimore, MD.

http://test-apps.humana.com/marketing/documents.asp?file=2574221

Impact of a step-therapy policy restriction for pregabalin on health care utilization and expenditures in a commercial population

Louder A, Udall M, Suehs BT, et al. Impact of a step-therapy policy restriction for pregabalin on health care utilization and expenditures in a commercial population. Poster presentation at: Academy of Managed Care Pharmacy Educational Conference. October 3-5, 2012; Cincinnati, OH.

http://apps.humana.com/marketing/documents.asp?file=2574208

Identifying schizophrenia patients at high-risk for antipsychotic nonadherence using the assessment for quality improvement and risk evaluation tool

Muser E, Slabaugh SL, Louder A, Patel N. Identifying schizophrenia patients at high-risk for antipsychotic nonadherence using the assessment for quality improvement and risk evaluation tool. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 18th Annual International Meeting. May 18-22, 2013; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2574195

Identification of undiagnosed COPD patients in a claims database using a predictive model

Saverno KR, Zhou Y, Moretz C, Renda A, Burslem K, Jain G, Hernandez G, Dhamane A. Identification of undiagnosed COPD patients in a claims database using a predictive model. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Scientific Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2332005

Heterogeneity of healthcare costs among Medicare Advantage patients with type 1 diabetes

Clore G, Slabaugh SL, Curtis BH, et al. Heterogeneity of healthcare costs among Medicare Advantage patients with type 1 diabetes. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting; May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2573961

Healthcare costs by level of adherence for infliximab patients with Crohn's disease

Michels SL, Eyck T, Vanderpoel J, et al. Healthcare costs by level of adherence for infliximab patients with Crohn's disease. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2573974

Factors associated with increased health care costs in Medicare Advantage patients with type 2 diabetes

Slabaugh SL, Curtis BH, Clore G, et al. Factors associated with increased health care costs in Medicare Advantage patients with type 2 diabetes. Poster presentation at: American Diabetes Association 74th scientific Sessions. June 13-17, 2014; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2574052

Evaluation of association between diabetes related quality measure achievement and diabetes complications in a Medicare Advantage population

Ellis J, Bouchard J, Saundankar V, Moll K, et al. Evaluation of association between diabetes related quality measure achievement and diabetes complications in a Medicare Advantage population.  Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574026

Evaluating the impact of a pay-for-outcomes program rewarding primary care physicians for optimal LDL-C management

Pasquale MK, Xu Y, Divers C, et al. Evaluating the impact of a pay-for-outcomes program rewarding primary care physicians for optimal LDL-C management. Poster presentation at: American Society of Health-System Pharmacists Mid-Year Clinical Meeting and Exhibition. December 2-6, 2012; Las Vegas, NV.

http://apps.humana.com/marketing/documents.asp?file=2574013

Economic burden of pain in a national health insurance plan

Pasquale M, Dufour R, Reiners AT, et al. Economic burden of pain in a national health insurance plan. Poster presentation at: Academy of Managed Care Pharmacy 25th Annual Meeting and Expo. April 2-5, 2013. San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2574000

Diabetes disease progression among a Medicare Advantage population - a retrospective analysis

Chiguluri V, Cusano D, Prewitt T, Gopal V, Painter P, Beveridge R. Diabetes disease progression among a Medicare Advantage population - a retrospective analysis. Poster presentation at: American Public Health Association 142nd Annual Meeting and Exposition. November 15-19, 2014; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2379260

Delayed treatment modifications for patients with type 2 diabetes mellitus (T2DM) with very poor glycemic control

Schwab P, Saundankar V, Bouchard J, et al. Delayed treatment modifications for patients with type 2 diabetes mellitus (T2DM) with very poor glycemic control. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://test-apps.humana.com/marketing/documents.asp?file=2345278

Data sources and structure for post-licensure rapid immunization safety monitoring (PRISM)

Selvan M, Lee G, Walraven C, et al. Data sources and structure for post-licensure rapid immunization safety monitoring. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574611

COPD-related exacerbation patterns and association with healthcare resource utilization and costs: a retrospective cohort study using an administrative claims database

Saverno K, Zhou Y, Moretz C, Renda A, et al. COPD-related exacerbation patterns and association with healthcare resource utilization and costs: a retrospective cohort study using an administrative claims database. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2331992

Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia

Ye X, Bays H, Schwab P, et al. Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 18th Annual International Meeting. May 18-22, 2013; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2573922

Comparative outcomes of patients newly initiating first-generation vs. second-generation tyrosine kinase inhibitors for chronic myeloid leukemia

Ward MA, Fang G, Richards K, et al. Comparative outcomes of patients newly initiating first-generation vs. second-generation tyrosine kinase inhibitors for chronic myeloid leukemia. Poster presentation at: Academy of Managed Care Pharmacy Nexus. October 7-10, 2014; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2452333

Comorbidity burden, health care resource utilization, and health care cost among Medicare Advantage members with Alzheimer's disease

Suehs B, Davis CD, Shah SN, et al. Comorbidity burden, health care resource utilization, and health care cost among Medicare Advantage members with Alzheimer's disease. Poster presentation at: Academy of Managed Care Pharmacy Educational Conference. October 3-5, 2012; Cincinnati, OH.

http://apps.humana.com/marketing/documents.asp?file=2573909

Clinical and economic outcomes associated with teriparatide adherence in Medicare Part D recipients: a retrospective cohort study

Hazel-Fernandez L, Louder AM, Foater SA, et al. Clinical and economic outcomes associated with teriparatide adherence in Medicare Part D recipients: a retrospective cohort study. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 17th Annual International Meeting. June 2-6, 2012; Washington, DC.

http://apps.humana.com/marketing/documents.asp?file=2573896

Claims-based algorithm targeting Medicare Advantage Prescription Drug (MAPD) members with chronic obstructive pulmonary disease (COPD) for care intervention

Worley K, Shenolikar R, Song F, et al.  Claims-based algorithm targeting Medicare Advantage Prescription Drug (MAPD) members with chronic obstructive pulmonary disease (COPD) for care intervention. Poster presentation at: American Society of Health Systems Pharmacists Midyear Clinical Meeting; December 4-8, 2011; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2573883

Cincinnati's adoption of a web-based portal to promote reportable evidence-based care

Loy B, Gallagher J, Peterson B, Forston S, Sturgill M. Cincinnati's adoption of a web-based portal to promote reportable evidence-based care. Poster presentation at: American Society of Clinical Oncology Quality Care Symposium. October 17-18, 2014; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2501603

Association between diabetes-related complications and healthcare resource use and costs in a large Medicare Advantage population

Hazel-Fernandez L. Association between diabetes-related complications and healthcare resource use and costs in a large Medicare Advantage population. Poster presentation at: American Diabetes Association's 73rd Scientific Sessions. June 21-25, 2013; Chicago, IL.

http://apps.humana.com/marketing/documents.asp?file=2573870

Anticoagulation treatment in high risk Medicare Advantage patients with non-valvular atrial fibrillation

Dye J, Louder A, Pasquale M. Anticoagulation treatment in high risk Medicare Advantage patients with non-valvular atrial fibrillation. Poster presentation at: American Heart Association Scientific Sessions. November 15-19, 2014; Chicago, IL.

http://apps.humana.com/marketing/documents.asp?file=2573844

Analysis of first dose observation data for MS treatment with fingolimod (DX14)

Schwab P, Zhou Y, Stemkowski S, et al. Analysis of first dose observation data for MS treatment with fingolimod. Poster presentation at: The Consortium for Multiple Sclerosis Centers and Americas Committee for Treatment and Research in Multiple Sclerosis 5th Cooperative Meeting. May 30-June 2, 2012; San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2645149

Analysis of a large payer claims database suggests elderly patients with diabetes are under-treated

Slabaugh SL, Yihua X, Stacy J, Patel N, Meah Y, Baltz J, Bouchard J. Analysis of a large payer claims database suggests elderly patients with diabetes are under-treated. Poster presentation at: American Diabetes Association 73rd Scientific Sessions. June 21-25, 2013; Chicago, IL.

http://apps.humana.com/marketing/documents.asp?file=2573818

An evaluation of cardiac procedures after use of a wearable cardioverter defibrillator

Tankersley MA, DeFrance A, Altonen B, Long J. An evaluation of cardiac procedures after use of a wearable cardioverter defibrillator. Poster presentation at: Society for Medical Decision Making 36th Annual North American Meeting. October 18-22, 2014; Miami, FL.

http://apps.humana.com/marketing/documents.asp?file=2477124

All-cause and driver-specific healthcare resource utilization in newly diagnosed non-valvular atrial fibrillation patients newly initiating dabigatran and warfarin

Michels SL, Sheer R, Ghate SR, Moretz C, Wang C, Stemkowski S, Sander SD, Andrews G. All-cause and driver-specific healthcare resource utilization in newly diagnosed non-valvular atrial fibrillation patients newly initiating dabigatran and warfarin. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Meeting & Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2332018

A retrospective cohort study to identify Medicare members at risk of low adherence to glaucoma medication

Sheer R, Bunniran S, Uribe C. A retrospective cohort study to identify Medicare members at risk of low adherence to glaucoma medication. Poster presentation at: Academy of Managed Care Pharmacy Nexus. October 7-10, 2014; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2645136

Medical chart abstraction to confirm diagnosis and WHO functional class of pulmonary arterial hypertension in patients identified via a U.S. retrospective claims database

Stemkowski S, Pruett J, Dufour R, Lane DC, Raspa S, Drake B. Medical chart abstraction to confirm diagnosis and WHO functional class of pulmonary arterial hypertension in patients identified via a U.S. retrospective claims database. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 17th Annual European Congress. November 8-14, 2014; Amsterdam, The Netherlands.

http://apps.humana.com/marketing/documents.asp?file=2645175

Quality of ultrasound images based on machine age

Anggelis E, Price S, Long C, Carneal G, Long J, Wilson T. Quality of ultrasound images based on machine age. Poster presentation at: American College of Radiology Annual Meeting. May 16-21, 2015; Washington, DC.

http://apps.humana.com/marketing/documents.asp?file=2633969

Risk of liver transplant in treated vs. untreated hepatitis C

Ems D, Racsa P, Anderson C, Gregory F, Worley K. Risk of liver transplant in treated vs. untreated hepatitis C. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 20th Annual International Meeting. May18-20, 2015; Philadelphia, PA.

https://apps.humana.com/marketing/documents.asp?file=2637778

Prescribing practices of antidepressant medications for treatment of major depressive disorder (MDD) among insured members (n=68,394)

Treviño LA, Treviño K,  Racsa P,  Biggan JR,  Gresky D, Gopal V. Prescribing practices of antidepressant medications for treatment of major depressive disorder (MDD) among insured members (n=68,394). Poster presentation at: American Psychiatric Association 168th Annual Meeting. May 16-20, 2015; Toronto, ON, Canada.

http://apps.humana.com/marketing/documents.asp?file=2640079

Longitudinal evaluation of a colorectal cancer screenings measurement model

Loy B, Brooks WT, Yang M, Happe LE, Van Gilder T. Longitudinal evaluation of a colorectal cancer screenings measurement model. J Natl Compr Canc Netw. 2015;13:624.

https://apps.humana.com/marketing/documents.asp?file=2584010

Comparing costs and health outcomes in initial therapy with sunitinib versus pazopanib for renal cell carcinoma

Racsa P, Worley K, Whisman T. Comparing costs and health outcomes in initial therapy with sunitinib versus pazopanib for renal cell carcinoma. J Natl Compr Canc Netw. 2015;13:625-26.

https://apps.humana.com/marketing/documents.asp?file=2584023

Are there differences in Healthy Days based on compliance to preventive health screening measures?

Havens E, Slabaugh SL, Pena J, Haugh G, Gopal V. Are there differences in Healthy Days based on compliance to health screening measures? Poster presentation at: Preventive Medicine 2015. February 25-28, 2015; Atlanta, GA.

https://apps.humana.com/marketing/documents.asp?file=2615002

An examination of influenza vaccination timing and risk of infection

Glasheen W, Renda A. An examination of influenza vaccination timing and risk of infection. Poster presentation at: Preventative Medicine 2015. February25-28, 2015; Atlanta, GA.

http://apps.humana.com/marketing/documents.asp?file=2583061

Podcast: https://www.brainshark.com/humana/fluvaccine

Use of coronary computed tomographic angiography as initial assessment of chest pain

Powell AC, DeFrance A, Haagensen S, Long JW, et al. Use of coronary computed tomographic angiography as initial assessment of chest pain. Circ Cardiovasc Qual Outcomes. 2015;8(Suppl 2):a262.

https://apps.humana.com/marketing/documents.asp?file=2631031

Integration of a substance abuse treatment program into population-based behavioral care

Weinstein LL, Gresky DP, Basaria N, Manejwala O, Gomari M. Integration of a substance abuse treatment program into population-based behavioral care. Poster presentation at: American Society of Addiction Medicine 46th Annual Conference. April 23-25, 2015; Austin, TX.

https://apps.humana.com/marketing/documents.asp?file=2614989

Is comorbid depression a risk factor for non-compliance with continuous positive airway pressure?  A historical cohort study

Weinstein L, Price S, Pickerell J, et al.  Is comorbid depression a risk factor for non-compliance with continuous positive airway pressure?  A historical cohort study. Poster presentation at: 36th Annual Meeting and Scientific Sessions of Society of Behavioral Medicine. April 22-25, 2015; San Antonio, TX.

https://apps.humana.com/marketing/documents.asp?file=2614976

Relationship between diabetes complications and health related quality of life among an elderly population in the United States

Chiguluri V, Guthikonda K, Slabaugh SL, Havens E, Pena J, Cordier T, Prewitt T, O'Connell K. Relationship between diabetes complications and health related quality of life among an elderly population in the United States. Poster Presentation at: American Diabetes Association 75th Scientific Session. June 5-9, 2015; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2642081

Treatment rates and prevalence of high priority comorbidities for treatment initiation in people with hepatitis C

Racsa P, Ems D, Anderson C, Gregory F, Worley K. Treatment rates and prevalence of high priority comorbidities for treatment initiation in people with hepatitis C. Poster presentation at: AcademyHealth Annual Research Meeting. June 14-16, 2015; Minneapolis, MN.

http://apps.humana.com/marketing/documents.asp?file=2645240

Activities of daily living are more closely correlated with health-related quality of life than medical diagnoses: evidence from two large US surveys

Havens E, Slabaugh SL, Pena J, Gopal V, Renda A, Prewitt T.  Activities of daily living are more closely correlated with health-related quality of life than medical diagnoses: evidence from two large US surveys. Poster presentation at: AcademyHealth Annual Research Meeting. June 14-16, 2015; Minneapolis, MN.

http://apps.humana.com/marketing/documents.asp?file=2641977

A retrospective investigation into primary care seeking behavior in Mississippi among newly insured Affordable Care Act exchange enrollees with a single national payer

Cordier TA,  Trunk L , Haugh GS, Happe LE, Beveridge RA, Gopal V, Beech BM. A retrospective investigation into primary care seeking behavior in Mississippi among newly insured Affordable Care Act exchange enrollees with a single national payer. Poster presentation at: AcademyHealth Annual Research Meeting. June 14-16, 2015; Minneapolis, MN.

http://apps.humana.com/marketing/documents.asp?file=2642627

Achy breaky heart - quality of life changes with progressing congestive heart failure

Cordier T, Slabaugh SL, Haugh G, Gopal V, Andrews G, Renda A. Achy breaky heart - quality of life changes with progressing congestive heart failure. Poster presentation at: Heart Failure Society of America 19th Annual Scientific Meeting. September 26-29, 2015; Baltimore, MD.

http://apps.humana.com/marketing/documents.asp?file=2771548

Incorporating patient preferences and priorities into end of life care

Rackow E, Ofori A, Rodkey W, Beveridge R. Incorporating patient preferences and priorities into end of life care. Poster presentation at: Palliative Care in Oncology Symposium. October 9-10, 2015; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2790385

Podcast: http://apps.humana.com/marketing/documents.asp?file=2838420

Prescribing practices of antidepressant medications for treatment of major depressive disorder (MDD) among insured members (n=68,394)

Treviño LA, Treviño K, Racsa P, Biggan JR, Gresky D, Gopal V. Prescribing practices of antidepressant medications for treatment of major depressive disorder (MDD) among insured members (n=68,394). Poster (encore) presentation at: American Psychiatric Association Institute on Psychiatric Services, The Mental Health Services Conference.  October 8-11, 2015; New York, NY.

http://apps.humana.com/marketing/documents.asp?file=2771561

Characteristics of and medication adherence for diabetic patients receiving dipeptidyl peptidase-4 inhibitors in the US Medicare and commercial insurance plans

Rascati K, Worley K, Meah Y, Everhart D. Characteristics of and medication adherence for diabetic patients receiving dipeptidyl peptidase-4 inhibitors in the US Medicare and commercial insurance plans. Poster presentation at: Academy of Managed Care Pharmacy Nexus Conference. October 26-29, 2015; Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=2799836

Patient-reported health related quality of life is strongly correlated to an objective index of comorbidity: results from a study of elderly U.S. patients

Cambon J, Cordier T, Slabaugh SL, Haugh G, Glasheen B, Gopal V, Renda A. Patient-reported health related quality of life is strongly correlated to an objective index of comorbidity: results from a study of elderly U.S. patients. Poster presentation at: International Society for Quality of Life Research 22nd Annual Conference. October 21-24, 2015; Vancouver, BC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2803242

Optimizing referral to renal care management program through use of a predictive model for transition to dialysis in a Medicare Advantage population

Dong Y, Hines H, Haugh G, Cockrell M, Prewitt T, Gopal V. Optimizing referral to renal care management program through use of a predictive model for transition to dialysis in a Medicare Advantage population. Poster presentation at: Society for Medical Decision Making 37th Annual North American Meeting. October 18-21, 2015; St. Louis, MO.

http://test-apps.humana.com/marketing/documents.asp?file=2800174

Factors associated with worsening health-related quality of life among a Medicare Advantage population

Fang X, Cordier T, Slabaugh SL, Haugh G, Pena J, Prewitt T, Gopal V. Factors associated with changes in health-related quality of life among an elderly Medicare Advantage population. Poster presentation at: American Public Health Association 143rd Annual Meeting and Expo. October 31-November 4, 2015; Chicago IL.

http://apps.humana.com/marketing/documents.asp?file=2801773

Does the association between behavioral health conditions and suicide attempts persist after accounting for chronic medical comorbidities?

Basaria N, Gresky D, Weinstein L, Gopal V. Does the association between behavioral health conditions and suicide attempts persist after accounting for chronic medical comorbidities? Poster presentation at: American Public Health Association 143rd Annual Meeting and Expo. October 31-November 4, 2015; Chicago IL.

http://apps.humana.com/marketing/documents.asp?file=2803840 

2014 trends in the Medicare Part D coverage gap

Mitchell B, Preston N, Relish M. 2014 trends in the Medicare Part D coverage gap. Poster presentation at: Academy of Managed Care Pharmacy Nexus conference. October 26-29, 2015; Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=2803008

Costs for diabetic patients receiving dipeptidyl peptidase-4 (DPP-4) inhibitors in US Medicare and commercial insurance plans

Rascati KL, Worley K, Everhart D, Meah Y. Costs for diabetic patients receiving dipeptidyl peptidase-4 (DPP-4) inhibitors in US Medicare and commercial insurance plans. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 18th Annual European Congress. November 7-11, 2015; Milan, Italy.

http://apps.humana.com/marketing/documents.asp?file=2819232

Preliminary evaluation of a holistic memory program for Hispanic patients with dementia

Castillo L, Santos S, Simon J, Gonsalves J. Preliminary evaluation of a holistic memory program for Hispanic patients with dementia. Poster presentation at: Lifestyle Medicine. November 1-4, 2015; Nashville, TN.

http://apps.humana.com/marketing/documents.asp?file=2821988

Employer-initiated investigation of physician stressors to inform well-being offerings

State T, Edwards ZC, Beveridge R, Schulz S, Blakemore D. Employer-initiated investigation of physician stressors to inform well-being offerings. Poster presentation at: Lifestyle Medicine. November 1-4, 2015; Nashville, TN.

http://apps.humana.com/marketing/documents.asp?file=2807636

Launching the CDC’s diabetes prevention program in a large employee population

Weaver L, Igleheart R, Radmacher M. Launching the CDC's diabetes prevention program in a large employee population. Poster presentation at: AcademyHealth Dissemination and Implementation. December 14-15, 2015; Washington, DC.

http://apps.humana.com/marketing/documents.asp?file=2826746

Do people who are adherent to their medications have fewer unhealthy days?

Cordier T, Slabuagh SL, Young P, Havens, E, Goapl V, Prewitt T. Do people who are adherent to their medications have fewer unhealthy days? Podium presentation at: Preventive Medicine. February 27, 2016; Washington DC.

http://apps.humana.com/marketing/documents.asp?file=2838862

Differences in maintenance vs. acute care between a rural and urban Mississippi Medicare Advantage population with diabetes; a cross-sectional analysis

Majercak K, John P, Hettel C, Eaker E, Renda A, Cusano D, Gopal V. Differences in maintenance vs. acute care between a rural and urban Mississippi Medicare Advantage population with diabetes; a cross-sectional analysis. Podium presentation at: American Public Health Association 143rd Annual meeting and Expo. October 31 - November 4, 2015. Chicago IL.

http://apps.humana.com/marketing/documents.asp?file=2807623http://apps.humana.com/marketing/documents.asp?file=2856906

Exploring the relationships between health-related quality of life and health conditions, costs, resource utilization and quality measures

Havens E, Pena J, Slabaugh SL, Cordier T, Renda A, Gopal V. Exploring the relationships between health-related quality of life and health conditions, costs, resource utilization and quality measures. Podium presentation at: International Society for Quality of Life Research 22nd Annual Conference. October 21-24, 2015. Vancouver, British Columbia.

http://apps.humana.com/marketing/documents.asp?file=2789059

Evaluating geographic relationship between people and provider by GIS

Luo L, Childers K, Yuan L, Feller S, Northam C, Gopal V. Evaluating geographic relationship between people and provider by GIS. Podium presentation at: Ersi User Conference. July 20-24, 2015. San Diego, CA.

Observational evaluation of preventive care services in fee-for-service vs. value-based arrangements

Caplan A, Havens E, Pena J, Olsen V, Holt W. Observational evaluation of preventive care services in fee-for-service vs. value-based arrangements. Podium presentation at: North American Primary Care Research Group Practice-based Research Network Conference. June 29-30, 2015. Bethesda, MD.

http://apps.humana.com/marketing/documents.asp?file=2651506

Are consumers, providers, and insurers aligned to advance the quality of health care? A survey of priorities and perceived performance

Miao M, Happe L, Wolfson L, Ash W, Andrews G. Are consumers, providers, and insurers aligned to advance the quality of health care? A survey of priorities and perceived performance. Podium presentation at: American College of Quality Medicine. March, 2015; Alexandria, VA.

Optimizing medical chart review sample size reduction with a Monte Carlo simulation

Wen Q, Yuan L, Feller S, Gopal V. Optimizing medical chart review sample size reduction with a Monte Carlo simulation. Podium presentation at: American Statistical Association Conference on Statistical Practice. February, 2015; New Orleans, LA.

A novel model for predicting future health risk and cost stratification at a member level

Chiu S, Zahedi H. A novel model for predicting future health risk and cost stratification at a member level.  Podium presentation at: SAS Analytics Conference Series. October, 2014; Las Vegas, NV.

A novel predictive model for identifying members at high risk of falling

Singh H.  A novel predictive model for identifying members at high risk of falling.  Podium presentation at: SAS Analytics Conference Series.  October, 2014; Las Vegas, NV.

Association between osteoporosis treatment change and total direct healthcare costs in Medicare Advantage Prescription Drug (MAPD) plan

Ward M.  Association between osteoporosis treatment change and total direct healthcare costs in Medicare Advantage Prescription Drug (MAPD) plan. Podium presentation at: Academy of Managed Care Pharmacy Educational Conference. October, 2011; Atlanta, GA.

Associations between osteoporosis treatment change, adherence, and incident fractures among members in a Medicare Advantage Prescription Drug (MAPD) plan

Xu Y.  Associations between osteoporosis treatment change, adherence, and incident fractures among members in a Medicare Advantage Prescription Drug (MAPD) plan. Podium presentation at: American Society for Bone and Mineral Research. September, 2011; San Diego, CA.

Bridging the gap: impact of Part D low income subsidy coverage or branded gap coverage on medication continuity among osteoporosis patients treated with teriparatide

Uribe C.  Bridging the gap: impact of Part D low income subsidy coverage or branded gap coverage on medication continuity among osteoporosis patients treated with teriparatide. Podium presentation at: AcademyHealth. June, 2009; Chicago, IL.

Call me maybe: lessons from recruitment strategies for a diabetes self-care program for a Medicare Advantage population

Radmacher M, Cordier T, Augspurger K, Haugh G, Gopal V. Call me maybe: lessons from recruitment strategies for a diabetes self-care program for a Medicare Advantage population. Podium presentation at: American Public Health Association 142nd Annual Meeting and Exposition. November, 2014; New Orleans, LA.

Do case rates affect physicians' clinical practice in radiation oncology?

Loy B, Royalty J, Shkedy C, Tankersley M, Altonen B. Do case rates affect physicians' clinical practice in radiation oncology? Podium presentation at: American Society of Clinical Oncology (ASCO) Quality Care Symposium. October, 2014; Boston, MA.

Electronically-transmitted prescriptions involved in primary prescription abandonment

Ellis J.  Electronically-transmitted prescriptions involved in primary prescription abandonment. Podium presentation at: Academy of Managed Care Pharmacy Nexus Meeting. October, 2014; Boston, MA.

Evaluating allopurinol therapy and serum uric acid (sUA) levels in Medicare beneficiaries with gout

Ward M.  Evaluating allopurinol therapy and serum uric acid (sUA) levels in Medicare beneficiaries with gout. Podium presentation at: American Geriatrics Society. May, 2012; Seattle, WA.

Evaluating characteristics of electronic prescriptions using pharmacy claims data

Slabaugh S. Evaluating characteristics of electronic prescriptions using pharmacy claims data.  Podium presentation at: Academy of Managed Care’s Annual Meeting & Showcase. April, 2012; San Francisco, CA.

Evaluating primary adherence using electronic prescription transactions

Constantino M.  Evaluating primary adherence using electronic prescription transactions. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting. April, 2011; Minneapolis, MN.

Evaluation of narcotic/acetaminophen prescription patterns and acetaminophen toxicity in a managed care population

Xu Y. Evaluation of narcotic/acetaminophen prescription patterns and acetaminophen toxicity in a managed care population. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting. April, 2010; San Diego, CA.

Evaluation of PQA draft measures of MTM performance

Ward M.  Evaluation of PQA draft measures of MTM performance. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting. April, 2011; Minneapolis, MN.

Evaluation of the impact of consumer messaging on medication treatment patterns

Louder A.  Evaluation of the impact of consumer messaging on medication treatment patterns. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting. April, 2010; San Diego, CA.

Exacerbations in chronic obstructive pulmonary disease patients from a predominantly Medicare population

Hartnett H.  Exacerbations in chronic obstructive pulmonary disease patients from a predominantly Medicare population. Podium presentation at: V World Asthma & COPD Forum. April, 2012; New York, NY.

Facilitating access to free diabetic retinal exams with a novel geospatial approach in a national Medicare Advantage population with diabetes

Bae E, Kwong R, Augspurger K, Haugh G, Gopal V.  Facilitating access to free diabetic retinal exams with a novel geospatial approach in a national Medicare Advantage population with diabetes. Podium presentation at: American Public Health Association Annual Meeting and Exposition. November, 2014; New Orleans, LA.

Healthcare utilization and costs associated with COPD patients from a predominantly Medicare population

Pasquale M.  Healthcare utilization and costs associated with COPD patients from a predominantly Medicare population.  Podium presentation at:  V World Asthma & COPD Forum. April, 2012; New York, NY.

Impact of celecoxib restrictions in Medicare beneficiaries with arthritis

Louder A.  Impact of celecoxib restrictions in Medicare beneficiaries with arthritis. Podium presentation at: Academy of Managed Care Pharmacy Educational Conference. October, 2010. St. Louis, MO.

Impact of generic conversion on cardiovascular medication adherence: a retrospective analysis in a managed care database

Ward M. Impact of generic conversion on cardiovascular medication adherence: a retrospective analysis in a managed care database. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting & Showcase. April, 2008; San Francisco, CA.

Impact of medication therapy management on formulary tier changes in a commercial population

Ward M. Impact of medication therapy management on formulary tier changes in a commercial population. Podium presentation at: Academy of Managed Care Pharmacy Educational Conference. October, 2008; Kansas City, Kansas.

Impact of out-of-pocket costs on initial and subsequent prescription refills among new initiators of biologic therapies indicated for RA

Saverno K, Pasquale M. Impact of out-of-pocket costs on initial and subsequent prescription refills among new initiators of biologic therapies indicated for RA. Oral presentation presented at: Academy of Managed Care Pharmacy. October, 2014; Boston, MA.

http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.14261

Impact of the Affordable Care Act on medication adherence in a population of Medicare Part D beneficiaries

Ward M.  Impact of the Affordable Care Act on medication adherence in a population of Medicare Part D beneficiaries. Oral presentation presented at: Academy of Managed Care Pharmacy Annual Meeting & Showcase. April, 2012; San Francisco, CA.

Patterns of osteoporosis treatment change in a Medicare Advantage prescription drug (MAPD) plan

Xu Y. Patterns of osteoporosis treatment change in a Medicare Advantage Prescription Drug (MAPD) plan. Oral presentation presented at: Academy of Managed Care Pharmacy Annual Meeting & Showcase. April, 2011;  Minneapolis, MN.

Peer-to-peer escalation of advanced diagnostic imaging requests in a utilization management program by facility rural-urban commuting area: rural providers need guidance more frequently

Hiatt K, Robinson JD, Hippe DS, Hiatt MD.  Peer-to-peer escalation of advanced diagnostic imaging requests in a utilization management program by facility rural-urban commuting area: rural providers need guidance more frequently. Podium presentation at: Radiological Society of North America Annual Meeting. December, 2013; Chicago, IL.

Predictive modeling in healthcare: advances in care management

Gopal V, Zahedi H. Predictive modeling in healthcare: advances in care management. Podium presentation at: SAS Analytics Conference. October, 2011; Orlando, Florida.

Reducing hospitalizations of frail seniors  by moving care and coordination from hospital to home

Rackow EC.  Reducing hospitalizations of frail seniors by moving care and coordination from hospital to home. Podium presentation at: 32nd Annual Meeting of the Southern Gerontological Society. April 2011. Raleigh, North Carolina.

The economic value to a health plan of certifying imaging provider groups

Hiatt M, Wilson T, Johnstad T. The economic value to a health plan of certifying imaging provider groups. Podium presentation at: Radiological Society of North America Annual Meeting. December 2013; Chicago, Illinois.

Use and costs of health care resources in fibromyalgia: a case-control comparison

Uribe C. Use and costs of health care resources in fibromyalgia: a case-control comparison. Podium presentation at: Academy of Managed Care Pharmacy 22nd Annual Meeting. April, 2010; San Diego, CA.

Using electronic media to model appropriate diabetes-related health behaviors: a randomized trial of a DVD intervention

Hazel-Fernandez L. Using electronic media to model appropriate diabetes-related health behaviors: a randomized trial of a DVD intervention. Podium presentation at: Society of Behavioral Medicine Annual Meeting. April, 2009; Montreal, Canada.

What can managed care claims data tell us about continuing medical education (CME) effectiveness?

Harkins T.  What Can Managed Care Claims Data Tell Us About Continuing Medical Education (CME) Effectiveness? Podium presentation at: Alliance for CME Annual Meeting. January, 2012; Orlando, FL.

Pharmacologic management of bipolar disorder in a Medicare Advantage population

Huang H, Gören JL, Chan YF, et al. Pharmacologic management of bipolar disorder in a Medicare Advantage population. Psychosomatics. 2014;55(6):572-7.

Pharmacologic management of bipolar disorder in a Medicare Advantage population. - PubMed - NCBI

Depression care and treatment in a chronically ill Medicare population

Huang H, Russo J, Bauer AM, et al. Depression care and treatment in a chronically ill Medicare population. Gen Hosp Psychiatry. 2013;35(4):382-6.

Depression care and treatment in a chronically ill Medicare population. - PubMed - NCBI

Validity of diagnostic codes to identify cases of severe acute liver injury in the U.S. Food and Drug Administration's Mini-Sentinel Distributed Database

Lo Re V 3rd, Haynes K, Goldberg D, et al. Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database. Pharmacoepidemiol Drug Saf. 2013;22(8):861-72.

http://www.ncbi.nlm.nih.gov/pubmed/23801638

Validation of anaphylaxis in the Food and Drug Administration’s Mini-Sentinel

Walsh KE, Cutrona SL, Foy S, et al. Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel. Pharmacoepidemiol Drug Saf. 2013;22(11):1205-13.

Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel. - PubMed - NCBI

Understanding predictors of opioid abuse: predictive model development and validation

Dufour R, Mardekian J, Pasquale M, Schaaf D, Andrews G, Patel N. Understanding predictors of opioid abuse: predictive model development and validation. Am J Pharm Benefits. 2014;6(5):208-216.

http://apps.humana.com/marketing/documents.asp?file=2574546

The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations

Dufour R, Joshi AV, Pasquale MK, et al. The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. Pain Pract. 2014;14(3):E106-15.

The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. - PubMed - NCBI

The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program

Forrow S, Campion DM, Herrinton LJ, et al. The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):12-7.

The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program.…

The influence of a postdischarge intervention on reducing hospital readmissions in a Medicare population

Costantino ME, Frey B, Hall B, Painter P. The influence of a postdischarge intervention on reducing hospital readmissions in a Medicare population. Popul Health Manag. 2013;16(5):310-6.

The influence of a postdischarge intervention on reducing hospital readmissions in a Medicare population. - PubMed - NC…

The clinical and economic burden of newly diagnosed Alzheimer's disease  in a Medicare Advantage population

Suehs BT, Davis CD, Alvir J, et al. The clinical and economic burden of newly diagnosed Alzheimer's disease in a Medicare advantage population. Am J Alzheimers Dis Other Demen. 2013;28(4):284-92.

The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population. - PubMed - …

The burden of diabetes mellitus for Medicare beneficiaries

Costantino ME, Stacy JN, Song F, Xu Y, Bouchard JR. The burden of diabetes mellitus for Medicare beneficiaries. Popul Health Manag. 2014;17(5):272-8.

The burden of diabetes mellitus for medicare beneficiaries. - PubMed - NCBI

Risk for fractures with centrally acting muscle relaxants: an analysis of a national Medicare Advantage claims database

Golden AG, Ma Q, Nair V, Florez HJ, Roos BA. Risk for fractures with centrally acting muscle relaxants: an analysis of a national Medicare Advantage claims database. Ann Pharmacother. 2010;44(9):1369-75.

Risk for fractures with centrally acting muscle relaxants: an analysis of a national Medicare Advantage claims database.…

Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage prescription drug plan population

Bergeson JG, Worley K, Louder A, Ward M, Graham J. Retrospective database analysis of the impact of prior authorization for Type 2 Diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population. J Manag Care Pharm.2013;19(5):374-84.

Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care cost…

Resource utilization and health care costs among diabetics with urinary tract infections in a commercially insured population

Worley K, Bell KF, Xu Y, Parasuraman S, Graham J. Resource utilization and health care costs among diabetics with urinary tract infections in a commercially insured population. J Clin Outcomes Mang. 2012;19(12):539-50.

Pharmacist-provided telephonic medication therapy management in an MAPD plan

Ward MA, Xu Y. Pharmacist-provided telephonic medication therapy management in an MAPD plan. Am J Manag Care. 2011;17(10):e399-409.

Pharmacist-provided telephonic medication therapy management in an MAPD plan. - PubMed - NCBI

Persistence with biologic therapies in the Medicare coverage gap

Tamariz L, Uribe CL, Luo J, et al. Persistence with biologic therapies in the Medicare coverage gap. Am J Manag Care. 2011;17(11):753-9.

Persistence with biologic therapies in the Medicare coverage gap. - PubMed - NCBI

Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug members in a national health plan

Xu Y, Viswanathan HN, Ward MA, et al. Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug in a national health plan. J Eval Clin Pract. 2013;19(1):50-9.

Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescrip…

Pain conditions ranked by healthcare costs for members of a national health plan

Pasquale MK, Dufour R, Schaaf D, et al. Pain conditions ranked by healthcare costs for members of a national health plan.  Pain Pract. 2014;14(2):117-31.

http://www.ncbi.nlm.nih.gov/pubmed/23601620

Out-of-pocket costs and prescription reversals: the case of oral linezolid

Pasquale MK, Louder AM, Deminski MC, Chambers RB, Haider S. Out-of-pocket costs and prescription reversals with oral linezolid. Am J Manag Care. 2013;19 (9):734-40.

Out-of-pocket costs and prescription reversals with oral linezolid. - PubMed - NCBI

http://apps.humana.com/marketing/documents.asp?file=2574273

Opioid-paracetamol prescription patterns and liver dysfunction: a retrospective cohort study in a population served by a US health benefits organization

Mort JR, Shiyanbola OO, Ndehi LN, Xu Y, Stacy JN. Opioid-paracetamol prescription patterns and liver dysfunction: a retrospective cohort study in a population served by a US health benefits organization. Drug Saf. 2011;34(11):1079-88.

Opioid-paracetamol prescription patterns and liver dysfunction: a retrospective cohort study in a population served by a…

Non-adherence to oral linezolid following hospitalization: a retrospective claims analysis of the incidence and consequence of claim reversals.

Ball AT, Xu Y, Sanchez RJ, Shelbaya A, Deminski MC, Nau DP. Non-adherence to oral linezolid following hospitalization: a retrospective claims analysis of the incidence and consequence of claim reversals. Clin Ther. 2010;32(13):2246-55.

Nonadherence to oral linezolid after hospitalization: a retrospective claims analysis of the incidence and consequence o…

Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia

Sanchez RJ, Uribe C, Li H, et al. Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin. 2011;27(3):663-71.

Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibro…

Lessons from the leucovorin shortage between 2009 and 2012 in a Medicare Advantage population: where do we go from here?

Hayes MS, Ward MA, Slabaugh SL, Xu Y. Lessons from the leucovorin shortage between 2009 and 2012 in a Medicare Advantage population: where do we go from here? Am Drug Health Benefits. 2014;7(5):264-270.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163778/

Intussusception risk after rotavirus vaccination in U.S. infants

Yih WK, Lieu TA, Kulldorff M, et al. Intussusception risk after rotavirus vaccination in U.S infants. N Engl J Med. 2014;370(6):503-12.

Intussusception risk after rotavirus vaccination in U.S. infants. - PubMed - NCBI

Inefficiencies in osteoarthritis and chronic low back pain management

Pasquale MK, Dufour R, Joshi AV, et al. Inefficiencies in osteoarthritis and chronic low back pain management. Am J Manag Care. 2013;19(10):816-23.

Inefficiencies in osteoarthritis and chronic low back pain management. - PubMed - NCBI

Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia

Ellis JJ, Sadosky AB, Ten Eyck LL, et al. Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia. Clinicoecon Outcomes Res. 2014;14(6):389-99.

Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare …

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population

Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi:10.2147/COPD.S36887.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients w…

Impact of certified CME in atrial fibrillation on administrative claims

Stowell SA, Gardner AJ, Alpert JS, et al. Impact of certified CME in atrial fibrillation on administrative claims. Am J Manag Care. 2012;18(5):253-60.

Impact of certified CME in atrial fibrillation on administrative claims. - PubMed - NCBI

Impact of celecoxib restrictions in Medicare beneficiaries with arthritis

Louder AM, Joshi AV, Ball AT, Cappelleri JC, Deminski MC, Sanchez RJ. Impact of celecoxib restrictions in Medicare beneficiaries with arthritis. Am J Mang Care. 2011;17(7):503-12.

Impact of Celecoxib restrictions in medicare beneficiaries with arthritis. - PubMed - NCBI

Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population.

Udall M, Louder A, Suehs BT, Cappelleri JC, Joshi AV, Patel NC. Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population. J Med Econ. 2013;16(6):784-92.

Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population. …

Impact of a pregabalin step therapy policy among Medicare Advantage beneficiaries

Suehs BT, Louder A, Udall M, Cappelleri JC, Joshi AV, Patel NC. Impact of a pregabalin step therapy policy among Medicare Advantage beneficiaries. Pain Pract. 2014;14(5):419-26.

Impact of a pregabalin step therapy policy among medicare advantage beneficiaries. - PubMed - NCBI

Household members of persons with Alzheimer's disease: health conditions, healthcare resource use, and healthcare costs

Suehs BT, Shah SN, Davis CD, et al. Household members of persons with Alzheimer's disease: health conditions, healthcare resource use, and healthcare costs. J Am Geriatr Soc. 2014;64(3):435-41.

Household members of persons with Alzheimer's disease: health conditions, healthcare resource use, and healthcare costs.…

Health economics perspective of the components of the cardiometabolic syndrome

Tamariz L, Palacio A, Yang T, Parris D, Ben-Joseph R, Florez H. Health economics perspective of the components of the cardiometabolic syndrome. J Clin Hypertens. 2010;12(7):549-55.

Health economics perspective of the components of the cardiometabolic syndrome. - PubMed - NCBI

Health care utilization and costs among patients with fibromyalgia in an insured population

Palacio AM, Uribe CL, Hua Li, et al. Health care utilization and costs among patients with fibromyalgia in an insured population. Am J Pharm Benefits. 2011;3(4):212-220.

Financial and clinical characteristics of fibromyalgia: a case-control comparison

Palacio A, Uribe CL, Li H, et al. Financial and clinical characteristics of fibromyalgia: a case-control comparison. Am J Manag Care. 2010;16(5 Suppl):S118-25.

Financial and clinical characteristics of fibromyalgia: a case-control comparison. - PubMed - NCBI

Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the United States

Slabaugh SL, Curtis BH, Clore G, et al.  Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the United States. J Med Econ. 2015;18(2):106-12.

Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a lar…

Design considerations, architecture, and use of the Mini-Sentinel distributed data system

Curtis LH, Weiner MG, Boudreau DM, et al. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf. 2012;21(Suppl1):23-31.

Design considerations, architecture, and use of the Mini-Sentinel distributed data system. - PubMed - NCBI

Cost drivers of prescription opioid abuse in commercial and Medicare populations

Pasquale MK, Joshi AV, Dufour R, et al. Cost drivers of prescription opioid abuse in commercial and Medicare populations. Pain Pract. 2014;14(3):16-25.

Cost drivers of prescription opioid abuse in commercial and Medicare populations. - PubMed - NCBI

Consumers’ misunderstanding of health insurance

Loewenstein G, Friedman JY, McGill B, et al. Consumers' misunderstanding of health insurance. J Health Econ. 2013;32(5):850-62.

Consumers' misunderstanding of health insurance. - PubMed - NCBI

Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costs

Ward MA, Fang G, Richards KL, et al. Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costs. Curr Med Res Opin. 2015;31(2):289-97.

Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors…

Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe

Schwab P, Louder A, Li Y, Mallick R, Bays H. Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe. Drugs Aging. 2014;31(9):683-94. doi: 10.1007/s40266-014-0200-6.

Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe. - Pu…

Can claims-based data be used to recruit black and Hispanic subjects into clinical trials?

Palacio AM, Tamariz LJ, Uribe C, et al. Can claims-based data be used to recruit black and Hispanic subjects into clinical trials? Health Serv Res. 2012;47(2):770-82. doi:10.1111/j.1475-6773.2011.01316.x.

Can claims-based data be used to recruit black and Hispanic subjects into clinical trials? - PubMed - NCBI

Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study

Hazel-Fernandez L, Louder AM, Foster SA, Uribe CL, Burge RT. Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study. BMC Musculoskelet Discord. 2013;14(4). doi:10.1186/1471-2474-14-4.

Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients:…

Association of out-of-pocket pharmacy costs with adherence to varenicline

Suehs BT, Davis C, Galaznik A, Joshi AV, Zou KH, Patel NC. Association of out-of-pocket pharmacy costs with adherence to varenicline. J Manag Care Pharm. 2014;20(6):592-600.

Association of out-of-pocket pharmacy costs with adherence to varenicline. - PubMed - NCBI

A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data

Tamariz L, Harkins T, Nair V. A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data. Pharmacoepidemiol Drug Saf. 2012;21(1 Suppl):148-53. doi:10.1002/pds.2340.

A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data. …

A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data

Tamariz L, Harkins T, Nair V. A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data. Pharmacoepidemiol Drug Saf. 2012;21(1 Suppl):154-62. doi:10.1002/pds.2341.

A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data. -…

A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC good practice task force report

Berger ML, Martin BC, Husereau D, et al. A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC good practice task force report. Value Health. 2014;17(2):143-56. doi:10.1016/j.jval.2013.12.011. Erratum in: Value Health. 2014;17(4):489.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217656/

Treatment interruption and regimen change in first-generation versus second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia

Ward MA, Fang G, Richards K, et al. Treatment interruption and regimen change in first-generation versus second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia. J Health Econ Outcomes Res. 2015;2(2):181-91.

A relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries

Hazel-Fernandez L, Li Y, Nero D, et al. A relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries.  Am J Manag Care. 2015;21(1):e62-70.

Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiari…

Is response guided therapy being applied in the clinical setting? The hepatitis C example.

Harris JB, Ward MA, Schwab P. Is response guided therapy being applied in the clinical setting? The hepatitis C example. Am Drug Health Benefits. 2015;8(1):22-8.

Is response-guided therapy being applied in the clinical setting? The hepatitis C example. - PubMed - NCBI

Re-initiation of withdrawn or modified neuroimaging requests after collaborative consultation

Powell AC, Hippe DS, Long JW, Robinson JD. Reinitiation of withdrawn or modified neuroimaging requests after collaborative consultation. Acad Radiol. 2015;22(11):1433-8.

Reinitiation of Withdrawn or Modified Neuroimaging Requests After Collaborative Consultation. - PubMed - NCBI

Two randomized controlled pilot trials of social forces to improve statin adherence among patients with diabetes

Reese PP, Kessler JB, Doshi JA, et al. Two randomized controlled pilot trials of social forces to improve statin adherence among patients with diabetes. J Gen Intern Med. 2016;31(4):402-10.

http://www.ncbi.nlm.nih.gov/pubmed/26585957

Comparing two tyrosine kinase inhibitors for treatment of advanced renal cell carcinoma in Medicare and commercially insured patients

Racsa PN, Whisman TR, Worley K. Comparing two tyrosine kinase inhibitors for treatment of advanced renal cell carcinoma in Medicare and commercially insured patients. Curr Med Res Opin. 2015;31(10):1933-40.

http://www.ncbi.nlm.nih.gov/pubmed/26368665

Descriptive analysis of patients initiating regorafenib therapy in a large managed care population

Slabaugh L, Louder A, Michels SL, et al. Descriptive analysis of patients initiating regorafenib therapy in a large managed care population. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2573987

Using sequence discovery to target outreach for diabetes medication adherence

Lopez A, Long CL, Happe LE, Relish M. Using sequence discovery to target outreach for diabetes medication adherence. Am J Manag Care. 2015;21(11):e601-e608

Using sequence discovery to target outreach for diabetes medication adherence. - PubMed - NCBI

Comprehensive Health Insights (CHI)

Refill patterns with oral oncolytic medications

Dye JT, Murty S, Nsiah I, Kennedy K, Whisman T, Worley K. Refill patterns with oral oncolytic medications. J Clin Oncol. 2016;34(suppl; abstr e18216).

Refill patterns with oral oncolytic medications. | 2016 ASCO Annual Meeting | Abstracts | Meeting Library

Is there a relationship between self-reported healthy days and comorbidity medication adherence among oncology patients?

A Casebeer, D Drzayich-Jankus, S Hopson,  R Khoury,  A Parikh, A Stein, T Michael, S Stemkowski, M Bunce.  Is there a relationship between self-reported healthy days and comorbidity medication adherence among oncology patients? Poster presented at: ASCO Quality of Care Symposium; February 2016; Phoenix, AZ.

http://test-apps.humana.com/marketing/documents.asp?file=2986152

The relative burden of community-acquired pneumonia hospitalizations compared to other serious conditions in the older population

Brown JD, Sheer RL, Null KD, Pasquale MK, Sato R.  The relative burden of community-acquired pneumonia hospitalizations compared to other serious conditions in the older population. JMCP 2016; 22(4-a); S89.

http://test-apps.humana.com/marketing/documents.asp?file=2986087

Correlates of unhealthy days in patients with metastatic breast, lung or colorectal cancer

Adrianne Casebeer, Dana Drzayich Antol, Sari Hopson,  Raya Khoury, Aparna Parikh, Alisha Stein, Todd Michael, Stephen Stemkowski and Mikele Bunce. Correlates of unhealthy days in patients with metastatic breast, lung or colorectal cancer.  Poster presented at ISPOR 21st Annual International Meeting; May 2016, Washington DC.

http://test-apps.humana.com/marketing/documents.asp?file=2986139

Does oncology patient reported healthcare experience vary by site of care (SOC)?

Dana Drzayich Jankus, Adrianne Casebeer, Sari Hopson, Joseph Dye, Zhuliang Tao, Stephen Stemkowski, Andrew Howe, Jeffrey Patton, Art Small and Anthony Masaquel.  Does oncology patient-reported healthcare experience vary by site of  care (SOC)? Presented at: ASCO Quality of Care Symposium; February 2016; Phoenix, AZ.

http://test-apps.humana.com/marketing/documents.asp?file=2986165

An evaluation of the abandonment of electronically transmitted prescriptions for warfarin and new oral anticoagulant agents

Gupta K., Tate N., Tao Z., Curtice TG, Stemkowski S, Lane DC. An evaluation of the abandonment of electronically transmitted prescriptions for warfarin and new oral anticoagulant agents. 65th American College of Cardiology Scientific Session and Expo. Chicago, IL. April 3, 2016

http://test-apps.humana.com/marketing/documents.asp?file=2986932

Treatment patterns, healthcare resource utilization, and costs associated with psoriatic arthritis among Humana commercial and medicare member populations

Mease P, Schwab P, Dinh H, Sheer R, Cappelleri JC, Bananis E, Harnett J, Hsu M-A. Treatment patterns, healthcare resource utilization, and costs associated with psoriatic arthritis among Humana commercial and Medicare member populations. JMCP 2016; 22(4-a):S100.

http://test-apps.humana.com/marketing/documents.asp?file=2987257

Understanding predictors of reaching serum uric acid goal in febuxostat utilizers

Sheer R, Null KD, Szmanski K, Sudharshan L, Pasquale MK. Understanding predictors of reaching serum uric acid (sUA) goal in febuxostat utilizers. SGIM 2016 May 11.

http://test-apps.humana.com/marketing/documents.asp?file=2986919

Predictors of early treatment modifications for uncontrolled type 2 diabetic medicare advantage prescription drug plan members

Abbass IM, Collins JC, Harvey RA, Suehs, Uribe C, Kimball ES, Bouchard JR, Renda AM, DeLuzio T, Allen E (2016, Apr). Predictors and Long Term Effects of Early Treatment Modifications in Diabetes- Member and provider factors that predict timely treatment modification (within 90 days) among diabetic Medicare Advantage members with HbA1c ≥ 9%. Poster presented at: Endocrine Society Annual Meeting; April 2016; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2856880

Medicare beneficiaries initiating mirabegron versus anti-muscarinic treatment for overactive bladder: patient reported adherence and claims based adherence rates

Davis C, Bunniran S, Suehs B, Kristy R, Schermer C, Ng D. Medicare beneficiaries initiating mirabegron versus anti-muscarinic treatment for overactive bladder: patient reported adherence and claims based adherence rates. AMCP Annual Meeting, April 19-22, 2016, San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2860039

A prospective study of medicare beneficiaries initiating mirabegron versus anti-muscarinic treatment: patient reported outcomes from the OAB-S (Overactive Bladder Satisfaction Scales)

Bunniran  S, Davis C, Suehs B, Kristy R, Schermer C, Ng D.  A prospective study of Medicare beneficiaries initiating mirabegron versus anti-muscarinic treatment: patient reported outcomes from the Overactive Bladder Satisfaction Scales (OAB-S). April 19-22, 2016, San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2860052

Demographic profiles of Medicare beneficiaries with overactive bladder initiating mirabegron versus anti-muscarinic treatment

Ng D, Kristy R, Schermer C, Davis C, Suehs B, Bunniran S. Demographic profiles of Medicare beneficiaries with overactive bladder initiating mirabegron versus anti-muscarinic treatment. American Geriatric Society Conference, May 19-21, 2016. Long Beach, CA.

http://apps.humana.com/marketing/documents.asp?file=2860026

Patient preference for route of administration among rheumatoid arthritis therapies: a conjoint analysis

Louder AM, Singh A, Saverno K, Cappelleri JC, Aten AJ, Koenig AS, Pasquale MK. Patient Preference for Route of Administration among Rheumatoid Arthritis Therapies: A Conjoint Analysis. AHDB 2016; 9(2):84-92.

Patient Preferences Regarding Rheumatoid Arthritis Therapies: A Conjoint Analysis. - PubMed - NCBI

Trends associated with implementing and lifting a pregabalin step therapy policy

Null K, Moll K, Sadosky A, Pasquale M, Cappelleri J, Parsons B. Trends associated with implementing and lifting a pregabalin step therapy policy. American Journal of Pharmacy Benefits 2016; 8(2):e17-e24.

Trends Associated with Implementing and Lifting a Pregabalin Step Therapy Policy

Predictors of type II diabetes treatment modification within 10-days post-acute discharge from an unplanned admission among medicare advantage

Abbass IM, Collins JC, Harvey RA, Suehs BT, Uribe C, Bouchard JR, Prewitt T, DeLuzio T, Allen E. Predictors of type II diabetes treatment modification within 10-days post-acute discharge from an unplanned admission among Medicare Advantage members. Poster presented at Academy of Managed Care Pharmacy Annual Meeting; April 2016; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2858453

Predictors of all cause hospitalization among medicare advantage members diagnosed with type II diabetes

Abbass IM, Collins JC, Harvey RA, Suehs, Uribe C, Bouchard JR, Prewitt T, DeLuzio T, Allen E (2016, Apr). Predictors of all cause hospitalization among Medicare Advantage members diagnosed with type II diabetes. Poster presented at: Academy of Managed Care Pharmacy Annual Meeting; April 2016; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2858427

Predictors of all cause 30-day readmission among type II diabetic medicare advantage members

Collins JC, Abbass IM, Harvey RA, Suehs, Uribe C, Bouchard JR, Prewitt T, DeLuzio T, Allen E. Predictors of type II diabetes treatment modification within 10-days post-acute discharge from an unplanned admission among Medicare Advantage Members. Poster presented at: Academy of Managed Care Pharmacy Annual Meeting; April 2016; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2858440

Patient and provider factors predicting adherence to oral anti-diabetic medication

Collins JC, Abbass IM, Harvey RA, Suehs, Uribe C, Kimball ES, Bouchard JR, Renda AM, DeLuzio T, Allen E. Patient and provider factors predicting adherence to oral anti-diabetic medication. Poster presented at: American Diabetes Association Annual Meeting; June 2016; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2892669

Predictors of change in adherence status from 1 year to the next among patients with type 2 diabetes mellitus on oral antidiabetes drugs

Saundankar V, Peng X, Fu H, Ascher-Svanum H, Rodriquez A, Ali A, Slabaugh SL, Young P, Louider A. Journal of Managed Care Specialty Pharmacy. 2016 May;22(5):467-82. doi: 10.18553/jmcp.2016.22.5.467.

http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.22.5.467

Predictors of change in adherence status from 1 year to the next among patients with type 2 diabetes mellitus on oral antidiabetes drugs

Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected

Raebel MA, Shetterly S, Lu CY, Flory J, Gagne JJ, Harrell FE, Haynes K, Herrinton LJ, Popovic J, Selvan M, Shoaibi A, Wang X, Roy J. Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected. Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):798-814. doi: 10.1002/pds.4015. Epub  2016 May 4.

Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies …

Effect of potentially inappropriate use of antimuscarinic medications on healthcare use and cost in individuals with overactive bladder

Suehs BT, Davis C, Franks B, Yuran TE, ng D, Knispel J, Vassilakis M, Berner T. Effect of potentially inappropriate use of antimuscarinic medications on healthcare use and cost in individuals with overactive bladder. J AM Geriatr Soc. 2016 Apr;64(4):779-87. doi: 10.1111/jgs.14030. Epub  2016 Apr 5.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Effect+of+Potentially+Inappropriate+Use+of+Antimuscarinic+Medications+on+Healthcare+Use+and+Cost+in+Individuals+with+Overactive+Bladder.

Leveraging health-related quality of life in population health management: the case for healthy days.

Slabaugh SL, Shah M, Zack M, Happe L, Cordier T, Havens E, Davidson E, Miao M, Prewitt T, Jia H. Leveraging health-related quality of life in population health management: the case for healthy days. Popul Health Manag. 2016 Mar 31

Leveraging Health-Related Quality of Life in Population Health Management: The Case for Healthy Days. - PubMed - NCBI

Does hepatitis C treatment adherence affect the risk of liver transplant? A historical cohort study

Ems E, Rasca P, Anderson C, Gregory F, Worley K, Brill J, Holt W. Does hepatitis C treatment adherence affect risk of liver transplantation? A historical cohort study. J Manag Care Pharm. 2016;22(7):863-71.

Does Hepatitis C Treatment Adherence Affect Risk of Liver Transplantation? A Historical Cohort Study. - PubMed - NCBI

Human papilloma virus vaccine initiation in an insured population

Espinosa C, Woods C, Marshall G, Happe L, Harkins T, Nair V, Knispel J, Van Amerongen V, Ma Q, Smith M. Human papilloma virus vaccine initiation in an insured population. Poster presentation at: Pediatric Academic Society. April 30-May 3, 2016; Baltimore, MD.

http://apps.humana.com/marketing/documents.asp?file=2882100

Comparative effectiveness analysis of rapid-acting insulin therapies in a large national health plan

Rasca P, Meah Y, Ellis JJ, Saverno K. Comparative effectiveness analysis of rapid-acting insulin therapies in a large national health plan. Poster presentation at: Academy of Managed Care & Specialty Pharmacy Annual Meeting. April 19-22, 2016; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2859935

Comparison of utilization and outcomes in patients with hemophilia receiving plasma-derived factors versus recombinant factors

Nsiah I, Aten A, Ellis J, Gregory F, Saverno, K. Comparison of utilization and outcomes in patients with hemophilia receiving plasma-derived factors versus recombinant factors. Poster presentation at: Academy of Managed Care & Specialty Pharmacy Annual Meeting. April 19-22, 2016; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2859584

Impact of out-of-pocket costs on initial and subsequent prescription refills among new initiators of biologic therapies indicated for RA

Hopson S, Saverno K, Liu LZ, AL-Sabbagh A, Orazem J, Pasquale MK. Impact of out-of-pocket costs on initial and subsequent prescription refills among new initiators of biologic therapies indicated for RA. JMCP 2016; 22(2):122-130.

Use of add-on treatment to metformin monotherapy for patients with type 2 diabetes and suboptimal glycemic control: a U.S. database study

Yu S, Schwab P, Bian B, Radican L, Tuncelli K. Use of add-on treatment to metformin monotherapy for patients with type 2 diabetes and suboptimal glycemic control: a U.S. database study. J Manag Care Spec Pharm. 2016;22(3):272-80.

http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.22.3.272

Patterns of care in patients with metastatic renal cell carcinoma among a US payer population

Miller LA, Stemkowski S, Saverno K, Lane D, Tao Z, Hackshaw M, Loy B. Patterns of care in patients with metastatic renal cell carcinoma among a US payer population. J Manag Care Spec Pharm, 2016;22(3):219-226

http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.22.3.219

Evaluation of molecular testing patterns in metastatic non-small cell lung cancer at a large US health plan

MacLean EA, Louder AM, Saverno KR, Smith G, Mardekian J, Bruins C, Ward M, Sweetman RW, Pasquale M. Evaluation of molecular testing patterns in metastatic non-small cell lung cancer at a large US health plan. American Journal of Managed Care 2016; 22(2): e60-e67.

Evaluation of molecular testing patterns in metastatic non-small cell lung cancer at a large U.S. health plan. | 2014 AS…

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs

Schwab P, Saundankar V, Bouchard J, Wintfeld N, Suehs B, Moretz C, Allen E, DeLuzio A. Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs. BMJ Open Diabetes Research and Care 2016;4:e000099. doi:10.1136/bmjdrc-2015-000099

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications,…

COPD exacerbations associated with the modified medical research council scale and COPD assessment test among Humana’s medicare members

Pasquale MK, Xu Y, Baker CL, Zou KH, Teeter JG, Renda AM, Davis CC, Lee TC, Bobula J. COPD exacerbations associated with the modified medical research council scale and COPD assessment test among Humana’s medicare members. International Journal of COPD 2016; 11:111-121.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716734/pdf/copd-11-111.pdf

Effect of new drug therapies on current metastatic melanoma treatment patterns

Kennedy K, Murty S, Dye J, Whisman T, Worley K. Effect of new drug therapies on current metastatic melanoma treatment patterns. J Natl Compr Canc Netw. 2016;14(5.5):e1-e30.

http://test-apps.humana.com/marketing/documents.asp?file=2852434

Variations in the rates of type 1 and type 2 diabetes in a managed care population stratified by age, geographic region, and insurance type

Slabaugh SL, Curtis B, Clore GS, et al. Variations in the rates of type 1 and type 2 diabetes in a managed care population stratified by age, geographic region, and insurance type. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2574572

Validation of febrile seizures identified in the mini-sentinel post-licensure rapid immunization safety monitoring (PRISM) system

Kawai AT, Martin D, McMahill-Walraven CN, et al. Validation of febrile seizures identified in the mini-sentinel post-licensure rapid immunization safety monitoring (PRISM) system. Poster presentation at: Infectious Disease Week. October 8-14, 2014; Philadelphia, PA.

http://apps.humana.com/marketing/documents.asp?file=2574559

Utilization of paliperidone long-acting injection among Medicare Advantage and Medicare Prescription Drug Plan members

Suehs B, Li Y, Howe A, et al. Utilization of paliperidone long-acting injection among Medicare Advantage and Medicare Prescription Drug Plan members. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 17th Annual International Meeting. June 2-6, 2012; Washington, DC.

http://apps.humana.com/marketing/documents.asp?file=2574546

Understanding predictors of opioid abuse: predictive model development and validation

Dufour R, Mardekian J, Pasquale MK, et al. Understanding predictors of opioid abuse: predictive model development and validation. Poster presentation at: Academy of Managed Care Pharmacy Nexus 2013. October 15-18, 2013; San Antonio, TX.

http://apps.humana.com/marketing/documents.asp?file=2574533

Understanding patient preferences associated with the use of biologic therapies for RA: results of a conjoint analysis

Louder A, Saverno K, Singh A. et al. Understanding patient preferences associated with the use of biologic therapies for RA: results of a conjoint analysis. Poster presentation at: American College of Rheumatology Annual Meeting. November 14-19, 2014; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2542995

The Humana database - a data source for pharmacoepidemiologic research

Michels SL, Uribe C. The Humana database - a data source for pharmacoepidemiologic research. Poster presentation at: 28th Annual International Conference for Pharmacoepidemiology and Therapeutic Risk Management. August 23-26, 2012; Barcelona, Spain.

http://apps.humana.com/marketing/documents.asp?file=2574520

Retrospective cohort analysis of the patterns and predictors of metformin treatment change in a Medicare Advantage patient population from a large national health plan

Hazel-Fernandez L, Xu Y, Moretz C, et al. Retrospective cohort analysis of the patterns and predictors of metformin treatment change in a Medicare Advantage patient population from a large national health plan. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574507

Relative adherence across sites of care for infliximab patients with Crohn's disease

Michels SL, Eyck T, Vanderpoel J, et al. Relative adherence across sites of care for infliximab patients with Crohn's disease. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574494

Racial/ethnic and gender differences in severity of diabetes-related complications, healthcare resource use, and costs among Medicare Advantage recipients

Hazel-Fernandez L, Li Y, Nero D, et al. Racial/ethnic and gender differences in severity of diabetes-related complications, healthcare resource use, and costs among Medicare Advantage recipients. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574481

Prevalence of opioid abuse and related costs in a commercial managed care population

Pasquale M, Joshi AV, Dufour R, et al. Prevalence of opioid abuse and related costs in a commercial managed care population. Poster presentation at: Academy of Managed Care Pharmacy Educational Conference. October 3-5, 2012; Cincinnati, OH.

http://apps.humana.com/marketing/documents.asp?file=2574468

Predictive meta-modeling to quantify future health risk and identify individuals for clinical programs aimed at improving health outcomes and quality of care

Chui S, Zahedi H, Gopal V. Predictive meta-modeling to quantify future health risk and identify individuals for clinical programs aimed at improving health outcomes and quality of care. Poster presentation at: Society for Medical Decision Making 36th Annual North American Meeting. October 18-22, 2014; Miami, FL.

http://apps.humana.com/marketing/documents.asp?file=2540824

Potential drug-drug interactions and opioid use among painful diabetic peripheral neuropathy Medicare members newly started on pregabalin or duloxetine

Eyck LT, Sadosky A, Ellis J, et al. Potential drug-drug interactions and opioid use among painful diabetics peripheral neuropathy Medicare members newly started on pregablin or duloxetine. Poster presentation at: American Diabetes Association 74th Scientific Sessions. June 13-17, 2014; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2574325

Patterns of lubiprostone utilization in a large managed care population

Sussman D, Tamariz L, Droege M, Harkins T, et al. Patterns of lubiprostone utilization in a large managed care population. Poster presentation at: Digestive Disease Week. May 1-5, 2010; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2574312

Patterns of lubiprostone use and costs in a large health benefits company

Sussman D, Tamariz L, Droege M, Harkins T, et al. Patterns of lubiprostone use and costs in a large health benefits company. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 15th Annual International Meeting. May 15-19, 2010; Atlanta, GA.

http://apps.humana.com/marketing/documents.asp?file=2574286

Out-of-pocket costs and prescription reversals: the case of oral linezolid

Pasquale M, Louder AM, Deminski MC, et al. Out-of-pocket costs and prescription reversals: the case of oral linezolid. Poster presentation at: Academy of Managed Care Pharmacy 25th Annual Meeting and Expo. April 2-5, 2013; San Diego, CA

http://apps.humana.com/marketing/documents.asp?file=2574273

Opportunities and challenges in providing face-to-face and telephonic MTM services to a commercially-insured population

Crawford S, Touchette DR, Sharp LK, et al. Opportunities and challenges in providing face-to-face and telephonic MTM services to a commercially-insured population. Poster presentation at: Academy of Managed Care Pharmacy Nexus. October 7-10, 2014; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2645188

Knee and hip replacements: changes in healthcare utilization and costs from pre- to post-surgery for Medicare Advantage members

Pasquale M, Louder A, Cheung RY, et al.  Knee and hip replacements: changes in healthcare utilization and costs from pre- to post-surgery for Medicare Advantage members.  Poster presentation at: American Pain Society Conference 33rd Annual Scientific Meeting. April 30-May 3, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2574247

Impact of roflumilast on COPD exacerbations, healthcare utilization and costs in a Medicare Advantage population

Ellis J, Sun SX, Moll K, et al. Impact of roflumilast on COPD exacerbations, healthcare utilization and costs in a Medicare Advantage population. Poster presentation at: American Thoracic Society International Conference. May 16-21, 2014; San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2574234

Impact of patient behaviors and attitudes on teriparatide adherence in a Medicare Part D population

Hazel-Fernandez L, Foater SA, Uribe C, et al. Impact of patient behaviors and attitudes on teriparatide adherence in a Medicare Part D population. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 16th Annual International Meeting. May 21-25, 2011; Baltimore, MD.

http://test-apps.humana.com/marketing/documents.asp?file=2574221

Impact of a step-therapy policy restriction for pregabalin on health care utilization and expenditures in a commercial population

Louder A, Udall M, Suehs BT, et al. Impact of a step-therapy policy restriction for pregabalin on health care utilization and expenditures in a commercial population. Poster presentation at: Academy of Managed Care Pharmacy Educational Conference. October 3-5, 2012; Cincinnati, OH.

http://apps.humana.com/marketing/documents.asp?file=2574208

Identifying schizophrenia patients at high-risk for antipsychotic nonadherence using the assessment for quality improvement and risk evaluation tool

Muser E, Slabaugh SL, Louder A, Patel N. Identifying schizophrenia patients at high-risk for antipsychotic nonadherence using the assessment for quality improvement and risk evaluation tool. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 18th Annual International Meeting. May 18-22, 2013; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2574195

Identification of undiagnosed COPD patients in a claims database using a predictive model

Saverno KR, Zhou Y, Moretz C, Renda A, Burslem K, Jain G, Hernandez G, Dhamane A. Identification of undiagnosed COPD patients in a claims database using a predictive model. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Scientific Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2332005

Heterogeneity of healthcare costs among Medicare Advantage patients with type 1 diabetes

Clore G, Slabaugh SL, Curtis BH, et al. Heterogeneity of healthcare costs among Medicare Advantage patients with type 1 diabetes. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting; May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2573961

Healthcare costs by level of adherence for infliximab patients with Crohn's disease

Michels SL, Eyck T, Vanderpoel J, et al. Healthcare costs by level of adherence for infliximab patients with Crohn's disease. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2573974

Factors associated with increased health care costs in Medicare Advantage patients with type 2 diabetes

Slabaugh SL, Curtis BH, Clore G, et al. Factors associated with increased health care costs in Medicare Advantage patients with type 2 diabetes. Poster presentation at: American Diabetes Association 74th scientific Sessions. June 13-17, 2014; San Francisco, CA.

http://apps.humana.com/marketing/documents.asp?file=2574052

Evaluation of association between diabetes related quality measure achievement and diabetes complications in a Medicare Advantage population

Ellis J, Bouchard J, Saundankar V, Moll K, et al. Evaluation of association between diabetes related quality measure achievement and diabetes complications in a Medicare Advantage population.  Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574026

Evaluating the impact of a pay-for-outcomes program rewarding primary care physicians for optimal LDL-C management

Pasquale MK, Xu Y, Divers C, et al. Evaluating the impact of a pay-for-outcomes program rewarding primary care physicians for optimal LDL-C management. Poster presentation at: American Society of Health-System Pharmacists Mid-Year Clinical Meeting and Exhibition. December 2-6, 2012; Las Vegas, NV.

http://apps.humana.com/marketing/documents.asp?file=2574013

Economic burden of pain in a national health insurance plan

Pasquale M, Dufour R, Reiners AT, et al. Economic burden of pain in a national health insurance plan. Poster presentation at: Academy of Managed Care Pharmacy 25th Annual Meeting and Expo. April 2-5, 2013. San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2574000

Delayed treatment modifications for patients with type 2 diabetes mellitus (T2DM) with very poor glycemic control

Schwab P, Saundankar V, Bouchard J, et al. Delayed treatment modifications for patients with type 2 diabetes mellitus (T2DM) with very poor glycemic control. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://test-apps.humana.com/marketing/documents.asp?file=2345278

Data sources and structure for post-licensure rapid immunization safety monitoring (PRISM)

Selvan M, Lee G, Walraven C, et al. Data sources and structure for post-licensure rapid immunization safety monitoring. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2574611

COPD-related exacerbation patterns and association with healthcare resource utilization and costs: a retrospective cohort study using an administrative claims database

Saverno K, Zhou Y, Moretz C, Renda A, et al. COPD-related exacerbation patterns and association with healthcare resource utilization and costs: a retrospective cohort study using an administrative claims database. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Meeting and Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2331992

Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia

Ye X, Bays H, Schwab P, et al. Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 18th Annual International Meeting. May 18-22, 2013; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2573922

Comparative outcomes of patients newly initiating first-generation vs. second-generation tyrosine kinase inhibitors for chronic myeloid leukemia

Ward MA, Fang G, Richards K, et al. Comparative outcomes of patients newly initiating first-generation vs. second-generation tyrosine kinase inhibitors for chronic myeloid leukemia. Poster presentation at: Academy of Managed Care Pharmacy Nexus. October 7-10, 2014; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2452333

Comorbidity burden, health care resource utilization, and health care cost among Medicare Advantage members with Alzheimer's disease

Suehs B, Davis CD, Shah SN, et al. Comorbidity burden, health care resource utilization, and health care cost among Medicare Advantage members with Alzheimer's disease. Poster presentation at: Academy of Managed Care Pharmacy Educational Conference. October 3-5, 2012; Cincinnati, OH.

http://apps.humana.com/marketing/documents.asp?file=2573909

Clinical and economic outcomes associated with teriparatide adherence in Medicare Part D recipients: a retrospective cohort study

Hazel-Fernandez L, Louder AM, Foater SA, et al. Clinical and economic outcomes associated with teriparatide adherence in Medicare Part D recipients: a retrospective cohort study. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 17th Annual International Meeting. June 2-6, 2012; Washington, DC.

http://apps.humana.com/marketing/documents.asp?file=2573896

Claims-based algorithm targeting Medicare Advantage Prescription Drug (MAPD) members with chronic obstructive pulmonary disease (COPD) for care intervention

Worley K, Shenolikar R, Song F, et al.  Claims-based algorithm targeting Medicare Advantage Prescription Drug (MAPD) members with chronic obstructive pulmonary disease (COPD) for care intervention. Poster presentation at: American Society of Health Systems Pharmacists Midyear Clinical Meeting; December 4-8, 2011; New Orleans, LA.

http://apps.humana.com/marketing/documents.asp?file=2573883

Association between diabetes-related complications and healthcare resource use and costs in a large Medicare Advantage population

Hazel-Fernandez L. Association between diabetes-related complications and healthcare resource use and costs in a large Medicare Advantage population. Poster presentation at: American Diabetes Association's 73rd Scientific Sessions. June 21-25, 2013; Chicago, IL.

http://apps.humana.com/marketing/documents.asp?file=2573870

Anticoagulation treatment in high risk Medicare Advantage patients with non-valvular atrial fibrillation

Dye J, Louder A, Pasquale M. Anticoagulation treatment in high risk Medicare Advantage patients with non-valvular atrial fibrillation. Poster presentation at: American Heart Association Scientific Sessions. November 15-19, 2014; Chicago, IL.

http://apps.humana.com/marketing/documents.asp?file=2573844

Analysis of first dose observation data for MS treatment with fingolimod (DX14)

Schwab P, Zhou Y, Stemkowski S, et al. Analysis of first dose observation data for MS treatment with fingolimod. Poster presentation at: The Consortium for Multiple Sclerosis Centers and Americas Committee for Treatment and Research in Multiple Sclerosis 5th Cooperative Meeting. May 30-June 2, 2012; San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2645149

Analysis of a large payer claims database suggests elderly patients with diabetes are under-treated

Slabaugh SL, Yihua X, Stacy J, Patel N, Meah Y, Baltz J, Bouchard J. Analysis of a large payer claims database suggests elderly patients with diabetes are under-treated. Poster presentation at: American Diabetes Association 73rd Scientific Sessions. June 21-25, 2013; Chicago, IL.

http://apps.humana.com/marketing/documents.asp?file=2573818

All-cause and driver-specific healthcare resource utilization in newly diagnosed non-valvular atrial fibrillation patients newly initiating dabigatran and warfarin

Michels SL, Sheer R, Ghate SR, Moretz C, Wang C, Stemkowski S, Sander SD, Andrews G. All-cause and driver-specific healthcare resource utilization in newly diagnosed non-valvular atrial fibrillation patients newly initiating dabigatran and warfarin. Poster presentation at: Academy of Managed Care Pharmacy 26th Annual Meeting & Expo. April 1-4, 2014; Tampa, FL.

http://apps.humana.com/marketing/documents.asp?file=2332018

A retrospective cohort study to identify Medicare members at risk of low adherence to glaucoma medication

Sheer R, Bunniran S, Uribe C. A retrospective cohort study to identify Medicare members at risk of low adherence to glaucoma medication. Poster presentation at: Academy of Managed Care Pharmacy Nexus. October 7-10, 2014; Boston, MA.

http://apps.humana.com/marketing/documents.asp?file=2645136

Medical chart abstraction to confirm diagnosis and WHO functional class of pulmonary arterial hypertension in patients identified via a U.S. retrospective claims database

Stemkowski S, Pruett J, Dufour R, Lane DC, Raspa S, Drake B. Medical chart abstraction to confirm diagnosis and WHO functional class of pulmonary arterial hypertension in patients identified via a U.S. retrospective claims database. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 17th Annual European Congress. November 8-14, 2014; Amsterdam, The Netherlands.

http://apps.humana.com/marketing/documents.asp?file=2645175

Risk of liver transplant in treated vs. untreated hepatitis C

Ems D, Racsa P, Anderson C, Gregory F, Worley K. Risk of liver transplant in treated vs. untreated hepatitis C. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 20th Annual International Meeting. May18-20, 2015; Philadelphia, PA.

https://apps.humana.com/marketing/documents.asp?file=2637778

Comparing costs and health outcomes in initial therapy with sunitinib versus pazopanib for renal cell carcinoma

Racsa P, Worley K, Whisman T. Comparing costs and health outcomes in initial therapy with sunitinib versus pazopanib for renal cell carcinoma. J Natl Compr Canc Netw. 2015;13:625-26.

https://apps.humana.com/marketing/documents.asp?file=2584023

Treatment rates and prevalence of high priority comorbidities for treatment initiation in people with hepatitis C

Racsa P, Ems D, Anderson C, Gregory F, Worley K. Treatment rates and prevalence of high priority comorbidities for treatment initiation in people with hepatitis C. Poster presentation at: AcademyHealth Annual Research Meeting. June 14-16, 2015; Minneapolis, MN.

http://apps.humana.com/marketing/documents.asp?file=2645240

Characteristics of and medication adherence for diabetic patients receiving dipeptidyl peptidase-4 inhibitors in the US Medicare and commercial insurance plans

Rascati K, Worley K, Meah Y, Everhart D. Characteristics of and medication adherence for diabetic patients receiving dipeptidyl peptidase-4 inhibitors in the US Medicare and commercial insurance plans. Poster presentation at: Academy of Managed Care Pharmacy Nexus Conference. October 26-29, 2015; Orlando, FL.

http://apps.humana.com/marketing/documents.asp?file=2799836

Costs for diabetic patients receiving dipeptidyl peptidase-4 (DPP-4) inhibitors in US Medicare and commercial insurance plans

Rascati KL, Worley K, Everhart D, Meah Y. Costs for diabetic patients receiving dipeptidyl peptidase-4 (DPP-4) inhibitors in US Medicare and commercial insurance plans. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 18th Annual European Congress. November 7-11, 2015; Milan, Italy.

http://apps.humana.com/marketing/documents.asp?file=2819232

Association between osteoporosis treatment change and total direct healthcare costs in Medicare Advantage Prescription Drug (MAPD) plan

Ward M.  Association between osteoporosis treatment change and total direct healthcare costs in Medicare Advantage Prescription Drug (MAPD) plan. Podium presentation at: Academy of Managed Care Pharmacy Educational Conference. October, 2011; Atlanta, GA.

Associations between osteoporosis treatment change, adherence, and incident fractures among members in a Medicare Advantage Prescription Drug (MAPD) plan

Xu Y.  Associations between osteoporosis treatment change, adherence, and incident fractures among members in a Medicare Advantage Prescription Drug (MAPD) plan. Podium presentation at: American Society for Bone and Mineral Research. September, 2011; San Diego, CA.

Bridging the gap: impact of Part D low income subsidy coverage or branded gap coverage on medication continuity among osteoporosis patients treated with teriparatide

Uribe C.  Bridging the gap: impact of Part D low income subsidy coverage or branded gap coverage on medication continuity among osteoporosis patients treated with teriparatide. Podium presentation at: AcademyHealth. June, 2009; Chicago, IL.

Electronically-transmitted prescriptions involved in primary prescription abandonment

Ellis J.  Electronically-transmitted prescriptions involved in primary prescription abandonment. Podium presentation at: Academy of Managed Care Pharmacy Nexus Meeting. October, 2014; Boston, MA.

Evaluating allopurinol therapy and serum uric acid (sUA) levels in Medicare beneficiaries with gout

Ward M.  Evaluating allopurinol therapy and serum uric acid (sUA) levels in Medicare beneficiaries with gout. Podium presentation at: American Geriatrics Society. May, 2012; Seattle, WA.

Evaluating characteristics of electronic prescriptions using pharmacy claims data

Slabaugh S. Evaluating characteristics of electronic prescriptions using pharmacy claims data.  Podium presentation at: Academy of Managed Care’s Annual Meeting & Showcase. April, 2012; San Francisco, CA.

Evaluating primary adherence using electronic prescription transactions

Constantino M.  Evaluating primary adherence using electronic prescription transactions. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting. April, 2011; Minneapolis, MN.

Evaluation of narcotic/acetaminophen prescription patterns and acetaminophen toxicity in a managed care population

Xu Y. Evaluation of narcotic/acetaminophen prescription patterns and acetaminophen toxicity in a managed care population. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting. April, 2010; San Diego, CA.

Evaluation of PQA draft measures of MTM performance

Ward M.  Evaluation of PQA draft measures of MTM performance. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting. April, 2011; Minneapolis, MN.

Evaluation of the impact of consumer messaging on medication treatment patterns

Louder A.  Evaluation of the impact of consumer messaging on medication treatment patterns. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting. April, 2010; San Diego, CA.

Exacerbations in chronic obstructive pulmonary disease patients from a predominantly Medicare population

Hartnett H.  Exacerbations in chronic obstructive pulmonary disease patients from a predominantly Medicare population. Podium presentation at: V World Asthma & COPD Forum. April, 2012; New York, NY.

Healthcare utilization and costs associated with COPD patients from a predominantly Medicare population

Pasquale M.  Healthcare utilization and costs associated with COPD patients from a predominantly Medicare population.  Podium presentation at:  V World Asthma & COPD Forum. April, 2012; New York, NY.

Impact of celecoxib restrictions in Medicare beneficiaries with arthritis

Louder A.  Impact of celecoxib restrictions in Medicare beneficiaries with arthritis. Podium presentation at: Academy of Managed Care Pharmacy Educational Conference. October, 2010. St. Louis, MO.

Impact of generic conversion on cardiovascular medication adherence: a retrospective analysis in a managed care database

Ward M. Impact of generic conversion on cardiovascular medication adherence: a retrospective analysis in a managed care database. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting & Showcase. April, 2008; San Francisco, CA.

Impact of medication therapy management on formulary tier changes in a commercial population

Ward M. Impact of medication therapy management on formulary tier changes in a commercial population. Podium presentation at: Academy of Managed Care Pharmacy Educational Conference. October, 2008; Kansas City, Kansas.

Impact of out-of-pocket costs on initial and subsequent prescription refills among new initiators of biologic therapies indicated for RA

Saverno K, Pasquale M. Impact of out-of-pocket costs on initial and subsequent prescription refills among new initiators of biologic therapies indicated for RA. Oral presentation presented at: Academy of Managed Care Pharmacy. October, 2014; Boston, MA.

http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.14261

Impact of the Affordable Care Act on medication adherence in a population of Medicare Part D beneficiaries

Ward M.  Impact of the Affordable Care Act on medication adherence in a population of Medicare Part D beneficiaries. Oral presentation presented at: Academy of Managed Care Pharmacy Annual Meeting & Showcase. April, 2012; San Francisco, CA.

Patterns of osteoporosis treatment change in a Medicare Advantage prescription drug (MAPD) plan

Xu Y. Patterns of osteoporosis treatment change in a Medicare Advantage Prescription Drug (MAPD) plan. Oral presentation presented at: Academy of Managed Care Pharmacy Annual Meeting & Showcase. April, 2011;  Minneapolis, MN.

Use and costs of health care resources in fibromyalgia: a case-control comparison

Uribe C. Use and costs of health care resources in fibromyalgia: a case-control comparison. Podium presentation at: Academy of Managed Care Pharmacy 22nd Annual Meeting. April, 2010; San Diego, CA.

Using electronic media to model appropriate diabetes-related health behaviors: a randomized trial of a DVD intervention

Hazel-Fernandez L. Using electronic media to model appropriate diabetes-related health behaviors: a randomized trial of a DVD intervention. Podium presentation at: Society of Behavioral Medicine Annual Meeting. April, 2009; Montreal, Canada.

Validity of diagnostic codes to identify cases of severe acute liver injury in the U.S. Food and Drug Administration's Mini-Sentinel Distributed Database

Lo Re V 3rd, Haynes K, Goldberg D, et al. Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database. Pharmacoepidemiol Drug Saf. 2013;22(8):861-72.

http://www.ncbi.nlm.nih.gov/pubmed/23801638

Validation of anaphylaxis in the Food and Drug Administration’s Mini-Sentinel

Walsh KE, Cutrona SL, Foy S, et al. Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel. Pharmacoepidemiol Drug Saf. 2013;22(11):1205-13.

Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel. - PubMed - NCBI

Understanding predictors of opioid abuse: predictive model development and validation

Dufour R, Mardekian J, Pasquale M, Schaaf D, Andrews G, Patel N. Understanding predictors of opioid abuse: predictive model development and validation. Am J Pharm Benefits. 2014;6(5):208-216.

http://apps.humana.com/marketing/documents.asp?file=2574546

The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations

Dufour R, Joshi AV, Pasquale MK, et al. The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. Pain Pract. 2014;14(3):E106-15.

The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. - PubMed - NCBI

The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program

Forrow S, Campion DM, Herrinton LJ, et al. The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):12-7.

The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program.…

The clinical and economic burden of newly diagnosed Alzheimer's disease  in a Medicare Advantage population

Suehs BT, Davis CD, Alvir J, et al. The clinical and economic burden of newly diagnosed Alzheimer's disease in a Medicare advantage population. Am J Alzheimers Dis Other Demen. 2013;28(4):284-92.

The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population. - PubMed - …

The burden of diabetes mellitus for Medicare beneficiaries

Costantino ME, Stacy JN, Song F, Xu Y, Bouchard JR. The burden of diabetes mellitus for Medicare beneficiaries. Popul Health Manag. 2014;17(5):272-8.

The burden of diabetes mellitus for medicare beneficiaries. - PubMed - NCBI

Risk for fractures with centrally acting muscle relaxants: an analysis of a national Medicare Advantage claims database

Golden AG, Ma Q, Nair V, Florez HJ, Roos BA. Risk for fractures with centrally acting muscle relaxants: an analysis of a national Medicare Advantage claims database. Ann Pharmacother. 2010;44(9):1369-75.

Risk for fractures with centrally acting muscle relaxants: an analysis of a national Medicare Advantage claims database.…

Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage prescription drug plan population

Bergeson JG, Worley K, Louder A, Ward M, Graham J. Retrospective database analysis of the impact of prior authorization for Type 2 Diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population. J Manag Care Pharm.2013;19(5):374-84.

Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care cost…

Resource utilization and health care costs among diabetics with urinary tract infections in a commercially insured population

Worley K, Bell KF, Xu Y, Parasuraman S, Graham J. Resource utilization and health care costs among diabetics with urinary tract infections in a commercially insured population. J Clin Outcomes Mang. 2012;19(12):539-50.

Pharmacist-provided telephonic medication therapy management in an MAPD plan

Ward MA, Xu Y. Pharmacist-provided telephonic medication therapy management in an MAPD plan. Am J Manag Care. 2011;17(10):e399-409.

Pharmacist-provided telephonic medication therapy management in an MAPD plan. - PubMed - NCBI

Persistence with biologic therapies in the Medicare coverage gap

Tamariz L, Uribe CL, Luo J, et al. Persistence with biologic therapies in the Medicare coverage gap. Am J Manag Care. 2011;17(11):753-9.

Persistence with biologic therapies in the Medicare coverage gap. - PubMed - NCBI

Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug members in a national health plan

Xu Y, Viswanathan HN, Ward MA, et al. Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug in a national health plan. J Eval Clin Pract. 2013;19(1):50-9.

Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescrip…

Pain conditions ranked by healthcare costs for members of a national health plan

Pasquale MK, Dufour R, Schaaf D, et al. Pain conditions ranked by healthcare costs for members of a national health plan.  Pain Pract. 2014;14(2):117-31.

http://www.ncbi.nlm.nih.gov/pubmed/23601620

Out-of-pocket costs and prescription reversals: the case of oral linezolid

Pasquale MK, Louder AM, Deminski MC, Chambers RB, Haider S. Out-of-pocket costs and prescription reversals with oral linezolid. Am J Manag Care. 2013;19 (9):734-40.

Out-of-pocket costs and prescription reversals with oral linezolid. - PubMed - NCBI

http://apps.humana.com/marketing/documents.asp?file=2574273

Opioid-paracetamol prescription patterns and liver dysfunction: a retrospective cohort study in a population served by a US health benefits organization

Mort JR, Shiyanbola OO, Ndehi LN, Xu Y, Stacy JN. Opioid-paracetamol prescription patterns and liver dysfunction: a retrospective cohort study in a population served by a US health benefits organization. Drug Saf. 2011;34(11):1079-88.

Opioid-paracetamol prescription patterns and liver dysfunction: a retrospective cohort study in a population served by a…

Non-adherence to oral linezolid following hospitalization: a retrospective claims analysis of the incidence and consequence of claim reversals.

Ball AT, Xu Y, Sanchez RJ, Shelbaya A, Deminski MC, Nau DP. Non-adherence to oral linezolid following hospitalization: a retrospective claims analysis of the incidence and consequence of claim reversals. Clin Ther. 2010;32(13):2246-55.

Nonadherence to oral linezolid after hospitalization: a retrospective claims analysis of the incidence and consequence o…

Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia

Sanchez RJ, Uribe C, Li H, et al. Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin. 2011;27(3):663-71.

Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibro…

Lessons from the leucovorin shortage between 2009 and 2012 in a Medicare Advantage population: where do we go from here?

Hayes MS, Ward MA, Slabaugh SL, Xu Y. Lessons from the leucovorin shortage between 2009 and 2012 in a Medicare Advantage population: where do we go from here? Am Drug Health Benefits. 2014;7(5):264-270.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163778/

Intussusception risk after rotavirus vaccination in U.S. infants

Yih WK, Lieu TA, Kulldorff M, et al. Intussusception risk after rotavirus vaccination in U.S infants. N Engl J Med. 2014;370(6):503-12.

Intussusception risk after rotavirus vaccination in U.S. infants. - PubMed - NCBI

Inefficiencies in osteoarthritis and chronic low back pain management

Pasquale MK, Dufour R, Joshi AV, et al. Inefficiencies in osteoarthritis and chronic low back pain management. Am J Manag Care. 2013;19(10):816-23.

Inefficiencies in osteoarthritis and chronic low back pain management. - PubMed - NCBI

Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia

Ellis JJ, Sadosky AB, Ten Eyck LL, et al. Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia. Clinicoecon Outcomes Res. 2014;14(6):389-99.

Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare …

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population

Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi:10.2147/COPD.S36887.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients w…

Impact of certified CME in atrial fibrillation on administrative claims

Stowell SA, Gardner AJ, Alpert JS, et al. Impact of certified CME in atrial fibrillation on administrative claims. Am J Manag Care. 2012;18(5):253-60.

Impact of certified CME in atrial fibrillation on administrative claims. - PubMed - NCBI

Impact of celecoxib restrictions in Medicare beneficiaries with arthritis

Louder AM, Joshi AV, Ball AT, Cappelleri JC, Deminski MC, Sanchez RJ. Impact of celecoxib restrictions in Medicare beneficiaries with arthritis. Am J Mang Care. 2011;17(7):503-12.

Impact of Celecoxib restrictions in medicare beneficiaries with arthritis. - PubMed - NCBI

Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population.

Udall M, Louder A, Suehs BT, Cappelleri JC, Joshi AV, Patel NC. Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population. J Med Econ. 2013;16(6):784-92.

Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population. …

Impact of a pregabalin step therapy policy among Medicare Advantage beneficiaries

Suehs BT, Louder A, Udall M, Cappelleri JC, Joshi AV, Patel NC. Impact of a pregabalin step therapy policy among Medicare Advantage beneficiaries. Pain Pract. 2014;14(5):419-26.

Impact of a pregabalin step therapy policy among medicare advantage beneficiaries. - PubMed - NCBI

Health economics perspective of the components of the cardiometabolic syndrome

Tamariz L, Palacio A, Yang T, Parris D, Ben-Joseph R, Florez H. Health economics perspective of the components of the cardiometabolic syndrome. J Clin Hypertens. 2010;12(7):549-55.

Health economics perspective of the components of the cardiometabolic syndrome. - PubMed - NCBI

Health care utilization and costs among patients with fibromyalgia in an insured population

Palacio AM, Uribe CL, Hua Li, et al. Health care utilization and costs among patients with fibromyalgia in an insured population. Am J Pharm Benefits. 2011;3(4):212-220.

Financial and clinical characteristics of fibromyalgia: a case-control comparison

Palacio A, Uribe CL, Li H, et al. Financial and clinical characteristics of fibromyalgia: a case-control comparison. Am J Manag Care. 2010;16(5 Suppl):S118-25.

Financial and clinical characteristics of fibromyalgia: a case-control comparison. - PubMed - NCBI

Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the United States

Slabaugh SL, Curtis BH, Clore G, et al.  Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the United States. J Med Econ. 2015;18(2):106-12.

Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a lar…

Design considerations, architecture, and use of the Mini-Sentinel distributed data system

Curtis LH, Weiner MG, Boudreau DM, et al. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf. 2012;21(Suppl1):23-31.

Design considerations, architecture, and use of the Mini-Sentinel distributed data system. - PubMed - NCBI

Cost drivers of prescription opioid abuse in commercial and Medicare populations

Pasquale MK, Joshi AV, Dufour R, et al. Cost drivers of prescription opioid abuse in commercial and Medicare populations. Pain Pract. 2014;14(3):16-25.

Cost drivers of prescription opioid abuse in commercial and Medicare populations. - PubMed - NCBI

Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costs

Ward MA, Fang G, Richards KL, et al. Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costs. Curr Med Res Opin. 2015;31(2):289-97.

Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors…

Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe

Schwab P, Louder A, Li Y, Mallick R, Bays H. Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe. Drugs Aging. 2014;31(9):683-94. doi: 10.1007/s40266-014-0200-6.

Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe. - Pu…

Can claims-based data be used to recruit black and Hispanic subjects into clinical trials?

Palacio AM, Tamariz LJ, Uribe C, et al. Can claims-based data be used to recruit black and Hispanic subjects into clinical trials? Health Serv Res. 2012;47(2):770-82. doi:10.1111/j.1475-6773.2011.01316.x.

Can claims-based data be used to recruit black and Hispanic subjects into clinical trials? - PubMed - NCBI

Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study

Hazel-Fernandez L, Louder AM, Foster SA, Uribe CL, Burge RT. Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study. BMC Musculoskelet Discord. 2013;14(4). doi:10.1186/1471-2474-14-4.

Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients:…

Association of out-of-pocket pharmacy costs with adherence to varenicline

Suehs BT, Davis C, Galaznik A, Joshi AV, Zou KH, Patel NC. Association of out-of-pocket pharmacy costs with adherence to varenicline. J Manag Care Pharm. 2014;20(6):592-600.

Association of out-of-pocket pharmacy costs with adherence to varenicline. - PubMed - NCBI

A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data

Tamariz L, Harkins T, Nair V. A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data. Pharmacoepidemiol Drug Saf. 2012;21(1 Suppl):148-53. doi:10.1002/pds.2340.

A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data. …

A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data

Tamariz L, Harkins T, Nair V. A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data. Pharmacoepidemiol Drug Saf. 2012;21(1 Suppl):154-62. doi:10.1002/pds.2341.

A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data. -…

A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC good practice task force report

Berger ML, Martin BC, Husereau D, et al. A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC good practice task force report. Value Health. 2014;17(2):143-56. doi:10.1016/j.jval.2013.12.011. Erratum in: Value Health. 2014;17(4):489.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217656/

Treatment interruption and regimen change in first-generation versus second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia

Ward MA, Fang G, Richards K, et al. Treatment interruption and regimen change in first-generation versus second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia. J Health Econ Outcomes Res. 2015;2(2):181-91.

A relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries

Hazel-Fernandez L, Li Y, Nero D, et al. A relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries.  Am J Manag Care. 2015;21(1):e62-70.

Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiari…

Is response guided therapy being applied in the clinical setting? The hepatitis C example.

Harris JB, Ward MA, Schwab P. Is response guided therapy being applied in the clinical setting? The hepatitis C example. Am Drug Health Benefits. 2015;8(1):22-8.

Is response-guided therapy being applied in the clinical setting? The hepatitis C example. - PubMed - NCBI

Comparing two tyrosine kinase inhibitors for treatment of advanced renal cell carcinoma in Medicare and commercially insured patients

Racsa PN, Whisman TR, Worley K. Comparing two tyrosine kinase inhibitors for treatment of advanced renal cell carcinoma in Medicare and commercially insured patients. Curr Med Res Opin. 2015;31(10):1933-40.

http://www.ncbi.nlm.nih.gov/pubmed/26368665

Descriptive analysis of patients initiating regorafenib therapy in a large managed care population

Slabaugh L, Louder A, Michels SL, et al. Descriptive analysis of patients initiating regorafenib therapy in a large managed care population. Poster presentation at: International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting. May 31-June 4, 2014; Montreal, QC, Canada.

http://apps.humana.com/marketing/documents.asp?file=2573987